# Milo-Lab - Full Knowledge File Milo-Lab is a research peptide shop offering pharmaceutical-grade compounds for laboratory and scientific research. All products are sold strictly for research use only and are not intended for human consumption. This file contains the full product knowledge base (mechanism summaries, frequently asked questions, and peer-reviewed study references) and the research guide articles. Canonical product URLs are included for citation. ## Categories - [Metabolic Peptides](https://milo-lab.com/categories/weight-management/): GLP-1, GIP and amylin receptor agonists and related metabolic compounds for receptor-level research. - [Cellular & Mitochondrial](https://milo-lab.com/categories/anti-aging/): Telomere, NAD+ and bioregulator compounds for cellular and mitochondrial research. - [Tissue Peptides](https://milo-lab.com/categories/recovery-repair/): Tissue-repair and anti-inflammatory peptides for regenerative research. - [Growth Hormone Axis](https://milo-lab.com/categories/performance-growth/): Growth-hormone secretagogues, GHRH analogues and IGF-1 variants for GH-axis research. - [Neuropeptides](https://milo-lab.com/categories/cognitive-neuro/): Neuroactive and neuroprotective peptides for central nervous system research. - [Reproductive Peptides](https://milo-lab.com/categories/sexual-health/): Melanocortin receptor agonists and reproductive peptides for receptor research. - [Immune Peptides](https://milo-lab.com/categories/immune-protection/): Thymic and immune-modulating peptides for immunity and protection research. - [Dermal Peptides](https://milo-lab.com/categories/skin-aesthetics/): Copper peptides, melanocortin agonists and collagen-modulating compounds for dermal research. - [Endocrine Peptides](https://milo-lab.com/categories/hormonal/): Gonadotropins and endocrine-support peptides for hormone-axis research. - [Accessories](https://milo-lab.com/categories/accessories/): Reconstitution solvents and supplies for peptide preparation and storage. - [Blends](https://milo-lab.com/categories/combos/): Pre-formulated multi-peptide blends supplied as single vials. ## Products ### 5-Amino-1MQ URL: https://milo-lab.com/products/5-amino-1mq/ 5-Amino-1MQ is a small-molecule NNMT inhibitor that raises NAD+ and SAM to support fat-cell metabolism, insulin sensitivity and healthy aging research. **Mechanism:** 5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT normally consumes S-adenosylmethionine (SAM) to methylate nicotinamide into 1-methylnicotinamide, a reaction that drains both SAM and NAD+ from the cell. By blocking this enzyme, 5-Amino-1MQ keeps NAD+ and SAM available at the same time. Higher NAD+ activates sirtuins, especially SIRT1, while restored SAM supports the cell methylation cycle. In adipocyte models, NNMT inhibition lowers fat-cell differentiation and lipid accumulation, which is why the compound is studied as a NAD+ booster that works by reducing consumption rather than by adding a precursor. **FAQ:** - Q: What is 5-Amino-1MQ? A: 5-Amino-1MQ is a small-molecule inhibitor of the enzyme NNMT (nicotinamide N-methyltransferase). By blocking NNMT it preserves cellular NAD+ and SAM, making it a research compound for metabolic health, fat-cell biology and healthy aging. Milo-Lab supplies it as a single 50mg vial. - Q: How does 5-Amino-1MQ work? A: NNMT consumes SAM to convert nicotinamide into 1-methylnicotinamide, depleting both SAM and NAD+. 5-Amino-1MQ inhibits NNMT, so NAD+ and SAM stay available. Higher NAD+ activates SIRT1, and in adipocyte models reduced NNMT activity lowers fat-cell differentiation and lipid storage. - Q: How does 5-Amino-1MQ differ from NMN or NR as a NAD+ booster? A: NMN and NR are precursors that raise NAD+ by adding biosynthetic substrate. 5-Amino-1MQ instead raises NAD+ by blocking its consumption through the NNMT pathway, and it also restores SAM for methylation reactions, a benefit precursors do not provide. The two approaches are complementary and are sometimes studied together. - Q: How should it be stored? A: Protected from light and moisture, sealed. The certificate of analysis states the tested storage period for the batch. **Referenced studies:** - NNMT inhibition activates a futile cycle that reduces fat mass and improves insulin sensitivity, Nature Medicine, 2013 (https://pubmed.ncbi.nlm.nih.gov/23455424/) ### AOD-9604 URL: https://milo-lab.com/products/aod9604/ AOD9604 (Anti-Obesity Drug 9604) is a synthetic fragment of human growth hormone (HGH) that targets fat metabolism without raising IGF-1. **Mechanism:** AOD9604 is a modified peptide built from the final amino acids (177-191) of human growth hormone, with a tyrosine added at position 177 for stability. This C-terminal fragment keeps the fat-mobilising (lipolytic) and fat-storage-blocking (anti-lipogenic) actions of intact HGH, yet omits the N-terminal region that triggers IGF-1 release. Because IGF-1 is not stimulated, AOD9604 avoids the anabolic and blood-sugar-raising (diabetogenic) effects of full growth hormone. Research indicates it acts on beta-3 adrenergic receptors in adipocytes, switching on lipolysis and suppressing lipogenesis through a pathway that is independent of the growth-promoting HGH signal. **FAQ:** - Q: What is AOD9604? A: AOD9604 (Anti-Obesity Drug 9604) is a synthetic peptide made from the C-terminal fragment (amino acids 177-191) of human growth hormone. It is studied as a research compound for fat metabolism because it triggers the lipolytic activity of HGH while leaving IGF-1, insulin and blood glucose unaffected. - Q: How does AOD9604 work? A: AOD9604 acts on beta-3 adrenergic receptors in fat cells, where it stimulates lipolysis (the breakdown of stored fat) and inhibits lipogenesis (the formation of new fat). Because it lacks the N-terminal signalling domain of growth hormone, it drives fat metabolism without the anabolic or growth-factor effects of the full HGH molecule. - Q: Which part of growth hormone is AOD9604? A: The C-terminal fragment covering residues 177 to 191 of human growth hormone, with a tyrosine added at position 177 for stability. It does not carry the sequence regions associated with IGF-1 signalling. - Q: What is its half-life? A: Roughly 30 to 60 minutes, consistent with a short peptide fragment. **Referenced studies:** - AOD9604: An anti-obesity drug with a good safety profile, Obesity Reviews, 2006 (https://pubmed.ncbi.nlm.nih.gov/16950159/) ### Bacteriostatic Water 10ml URL: https://milo-lab.com/products/bacteriostatic-water/ Bacteriostatic water is 0.9% benzyl-alcohol-preserved sterile water used to reconstitute lyophilised research peptides. 10ml vial, for laboratory use only. **Mechanism:** Bacteriostatic water is sterile water for injection preserved with approximately 0.9% benzyl alcohol. Unlike plain sterile water, the benzyl alcohol content inhibits bacterial growth within the solution once a vial has been punctured, which is why it is the standard solvent used in laboratory settings to reconstitute lyophilised (freeze-dried) peptides into a liquid, usable solution. It does not react with or alter the peptide itself; its role is purely as a diluent, controlling the concentration (mg per ml) of the reconstituted solution rather than the total peptide quantity in the vial. Because it is preserved rather than sterile-only, a bacteriostatic water vial can be safely drawn from multiple times across its shelf life, provided sterile technique is maintained at each draw. **FAQ:** - Q: Can I buy bacteriostatic water on its own? A: No. Bacteriostatic water is supplied as a reconstitution accessory alongside a peptide order, not as a standalone purchase. Add at least one peptide to your cart to include bacteriostatic water in the same order. - Q: How should bacteriostatic water be stored? A: Store unopened vials at room temperature, away from direct light. Once punctured, keep refrigerated (2-8°C) and use within the vial's labelled shelf life, commonly referenced as up to 28 days, discarding it sooner if the solution becomes cloudy or shows visible particulate. - Q: What makes it bacteriostatic? A: Approximately 0.9% benzyl alcohol, added as a preservative. That is the entire difference from plain sterile water: the benzyl alcohol inhibits bacterial growth in the solution once the stopper has been punctured. - Q: When is plain sterile water used instead? A: Where benzyl alcohol would interfere with the work, or where a peptide is known to be sensitive to it. Some degradation-sensitive peptides are handled in dilute acetic acid instead. ### BPC-157 URL: https://milo-lab.com/products/bpc-157/ BPC-157 (Body Protective Compound) is a stable pentadecapeptide derived from human gastric juice, researched for tendon, gut and tissue repair. **Mechanism:** BPC-157 is a synthetic 15-amino-acid peptide based on a sequence found in human gastric juice, which is why it is called Body Protective Compound. It works mainly by driving new blood-vessel growth: it upregulates VEGF and the VEGFR2 receptor to fuel angiogenesis at injury sites. In parallel it activates the FAK-paxillin signalling pathway, which speeds fibroblast migration and the laying down of new collagen and connective tissue. BPC-157 also modulates the nitric-oxide (NO) system to dampen inflammation, and it interacts with growth-hormone receptor expression to support tissue regeneration. In the digestive tract it stabilises the mucosal lining and counteracts NSAID-induced damage by protecting the microvascular integrity of the gastrointestinal wall. **FAQ:** - Q: What is BPC-157? A: BPC-157 (Body Protective Compound) is a synthetic pentadecapeptide, a chain of 15 amino acids based on a protein sequence found in human gastric juice. In research it is studied for its ability to accelerate the repair of tendons, ligaments, muscle and the gut lining, mainly by promoting new blood-vessel growth and collagen formation. - Q: How does BPC-157 work? A: BPC-157 promotes healing by upregulating VEGF-driven angiogenesis, which brings fresh blood supply to damaged tissue, and by activating the FAK-paxillin pathway to speed fibroblast migration and collagen synthesis. It also modulates the nitric-oxide system to reduce inflammation and protects the gastric mucosa against NSAID-induced damage. - Q: Can BPC-157 be stacked with TB-500? A: Yes, BPC-157 and TB-500 are commonly co-administered in research. They act through complementary pathways: BPC-157 via angiogenesis and the FAK pathway, and TB-500 via actin polymerisation and cell migration. Together they target different phases of the tissue-repair cascade and may produce additive effects. - Q: Is BPC-157 sold for sale as a research chemical, not a supplement? A: Yes. BPC-157 for sale through Milo-Lab is classified and labelled as a research chemical for laboratory use only, not a dietary supplement or medicine. It is supplied strictly for laboratory research use. **Referenced studies:** - BPC 157 and standard angiogenic growth factors: gastrointestinal tract healing, Curr Pharm Des, 2009 (https://pubmed.ncbi.nlm.nih.gov/19943067/) - Stable gastric pentadecapeptide BPC 157: novel therapy of a tumor cachexia, J Physiol Pharmacol, 2008 (https://pubmed.ncbi.nlm.nih.gov/18029612/) - BPC 157 effects on achilles tendon healing, J Orthop Res, 1999 (https://pubmed.ncbi.nlm.nih.gov/10418062/) - Pentadecapeptide BPC 157 accelerates healing and rescues ovariectomized rats, J Physiol Pharmacol, 2014 (https://pubmed.ncbi.nlm.nih.gov/25261903/) ### Cagrilintide URL: https://milo-lab.com/products/cagrilintide/ Cagrilintide is a long-acting amylin analogue for once-weekly research use, studied for satiety signalling alone and combined with semaglutide. **Mechanism:** Amylin is co-secreted with insulin by pancreatic beta cells and signals through amylin receptors, formed by the calcitonin receptor paired with RAMP1, RAMP2 or RAMP3 subunits, concentrated in the area postrema of the hindbrain. Cagrilintide is an acylated long-acting analogue: its fatty-acid side chain binds albumin reversibly, which extends plasma exposure well beyond that of native amylin. It also retains affinity for the calcitonin receptor itself, making it a dual amylin and calcitonin receptor agonist. **FAQ:** - Q: How does cagrilintide differ from semaglutide or tirzepatide? A: Cagrilintide acts on amylin and calcitonin receptors, not on the GLP-1 or GIP receptors. It is a separate satiety pathway rather than a stronger version of the same one, which is why trials pair it with semaglutide instead of substituting it. - Q: What receptors does cagrilintide bind? A: Amylin receptors, which are formed by the calcitonin receptor paired with RAMP1, RAMP2 or RAMP3 subunits, and the calcitonin receptor itself. That makes it a dual amylin and calcitonin receptor agonist. - Q: Why is it described as long-acting? A: Its fatty-acid side chain binds albumin reversibly, which extends plasma exposure well beyond that of native amylin. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry. It is available on request before ordering. **Referenced studies:** - Once-weekly cagrilintide for weight management in people with overweight and obesity: a dose-finding phase 2 trial, The Lancet, 2021 (https://pubmed.ncbi.nlm.nih.gov/34798060/) - Coadministered cagrilintide and semaglutide in adults with overweight or obesity (REDEFINE 1), New England Journal of Medicine, 2025 (https://pubmed.ncbi.nlm.nih.gov/40544433/) - Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone, Lancet Diabetes Endocrinol, 2026 (https://pubmed.ncbi.nlm.nih.gov/42009015/) ### Cerebrolysin URL: https://milo-lab.com/products/cerebrolysin/ Cerebrolysin is a neuropeptide complex from porcine brain proteins that mimics BDNF, NGF and GDNF for cognition and neuro-recovery research. **Mechanism:** Cerebrolysin is a standardised peptide complex obtained by enzymatic hydrolysis of purified porcine brain proteins, yielding low molecular weight neuropeptides alongside free amino acids. Its small active fractions are able to cross the blood-brain barrier, where they reproduce the signalling of endogenous neurotrophic factors such as BDNF, NGF, GDNF and NT-3. By engaging Trk-family receptors (TrkB, TrkA) and the GDNF co-receptor RET, the peptides trigger MAPK/ERK and PI3K/Akt cascades that support neuronal survival, strengthen synaptic plasticity, and drive adult neurogenesis in the hippocampal dentate gyrus. Parallel effects include reduced oxidative stress and lower beta-amyloid oligomer toxicity, which together underpin its use in cognitive-decline and neuro-recovery research. **FAQ:** - Q: What is cerebrolysin? A: Cerebrolysin is a standardised neuropeptide preparation made by enzymatically hydrolysing purified porcine brain proteins. It contains low molecular weight peptide fragments and free amino acids that mimic neurotrophic factors such as BDNF and NGF, and it is studied for cognition, neuroprotection and recovery after neurological injury. - Q: How does cerebrolysin work in the brain? A: The small peptide fractions cross the blood-brain barrier and act like endogenous neurotrophins. They activate TrkB, TrkA and RET receptors, switching on MAPK/ERK and PI3K/Akt signalling that promotes neuronal survival, synaptic plasticity and hippocampal neurogenesis while limiting oxidative and amyloid-related stress. - Q: Is cerebrolysin approved by regulatory authorities? A: Cerebrolysin (EVER Neuro Pharma, Austria) is approved as a pharmaceutical in over 50 countries, including Germany, Austria, China and Russia, for Alzheimer's disease and stroke recovery. It is not FDA-approved in the United States, where it is handled strictly as a research compound. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry. It is available on request before ordering. **Referenced studies:** - Cerebrolysin in Alzheimer's disease: systematic review and meta-analysis, J Alzheimers Dis, 2015 (https://pubmed.ncbi.nlm.nih.gov/25888194/) - Cerebrolysin in acute ischaemic stroke: CASTA trial, Stroke, 2012 (https://pubmed.ncbi.nlm.nih.gov/22987103/) - Neuropeptide fractions of cerebrolysin stimulate neurogenesis, J Neural Transm, 2005 (https://pubmed.ncbi.nlm.nih.gov/15927745/) ### CJC-1295 (no DAC) URL: https://milo-lab.com/products/cjc-1295-no-dac/ CJC-1295 without DAC (Mod GRF 1-29) is a short-acting GHRH analogue that triggers pulsatile growth hormone release for muscle, recovery and fat-loss research. **Mechanism:** CJC-1295 without DAC, also known as Modified GRF 1-29, is a stabilised fragment of growth-hormone-releasing hormone (GHRH 1-29) carrying four amino-acid substitutions that block enzymatic breakdown without the albumin-binding Drug Affinity Complex. It binds the pituitary GHRH receptor on somatotroph cells and couples through the Gs protein to activate adenylyl cyclase, raising intracellular cAMP and amplifying growth-hormone synthesis and release. Because no DAC is attached, the peptide clears in roughly 30 minutes, so it reinforces the body's own GH pulses instead of flooding the system with a continuous elevation. This short, pulsatile signature preserves GHRH receptor sensitivity and mirrors physiological secretion more closely than the DAC-bound version. **FAQ:** - Q: What is CJC-1295 without DAC? A: CJC-1295 without DAC (Mod GRF 1-29) is a synthetic growth-hormone-releasing hormone analogue used in performance and recovery research. It is the GHRH 1-29 fragment with four amino-acid substitutions that extend its stability, so it stimulates the pituitary to release growth hormone in short, natural pulses. Milo-Lab supplies it as 10mg, 25mg and 50mg vial formats. - Q: How does CJC-1295 without DAC work? A: It binds the GHRH receptor on pituitary somatotroph cells and activates adenylyl cyclase through Gs-protein coupling, which raises cAMP and amplifies growth-hormone synthesis. With no albumin-binding DAC, it clears in about 30 minutes, reinforcing the body's own GH pulses rather than holding GH continuously elevated. - Q: Why is CJC-1295 without DAC also called Mod GRF 1-29? A: Native GHRH has 44 amino acids and its active fragment is residues 1-29 (GRF 1-29, also marketed as Sermorelin). CJC-1295 without DAC modifies that fragment at positions 2, 8, 15 and 27 to resist enzymatic degradation, hence Modified GRF 1-29. The substitutions extend stability from roughly 7 minutes to about 30 minutes. - Q: Can CJC-1295 without DAC be used alone without ipamorelin? A: It can, but the effect is markedly weaker. On its own CJC-1295 without DAC amplifies GH release only modestly, because there is no GHRP co-stimulation. Pairing it with ipamorelin produces synergistic GH release reported at 3-5x the level seen with CJC-1295 alone. **Referenced studies:** - Mod GRF 1-29: enhanced stability GHRH analogue, Biochem Biophys Res Commun, 1988 (https://pubmed.ncbi.nlm.nih.gov/2831051/) - GHRH analogue potency and receptor selectivity, Endocrinology, 1999 (https://pubmed.ncbi.nlm.nih.gov/10340967/) ### DSIP URL: https://milo-lab.com/products/dsip/ DSIP (Delta Sleep-Inducing Peptide) is an endogenous nonapeptide that promotes deep delta-wave (slow-wave) sleep and buffers stress-driven cortisol. **Mechanism:** DSIP is a naturally occurring nine-amino-acid neuropeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from rabbit brain. It acts on hypothalamic targets to shift sleep architecture toward delta-wave (slow-wave) sleep, the deepest and most restorative NREM stage. In parallel it modulates the hypothalamic-pituitary-adrenal (HPA) axis, blunting stress-induced cortisol release without globally suppressing normal adrenal output, and it helps normalise luteinizing hormone (LH) pulsatility. Additional reported actions include modulation of the growth-hormone (GH) axis, natural killer (NK) cell activity, and weak but reproducible antinociceptive effects, likely through opioid-system signalling. The result is a peptide studied less as a sedative and more as a regulator of sleep depth and neuroendocrine stress balance. **FAQ:** - Q: What is DSIP? A: DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated from rabbit brain. It is studied for its ability to promote delta-wave (slow-wave) sleep, the deepest restorative sleep stage, and to modulate the HPA stress axis by lowering cortisol responses. Milo-Lab supplies it as a single 5mg vial for research use. - Q: How does DSIP promote sleep differently from melatonin? A: Melatonin signals circadian darkness and mainly influences sleep-onset timing. DSIP instead promotes delta (slow-wave) sleep, the deepest and most restorative stage, which drives most nightly GH release, declarative memory consolidation, and cellular repair. The two act on separate pathways, so they are complementary and can be studied together. - Q: What is the relationship between DSIP and the HPA axis? A: DSIP modulates the hypothalamic-pituitary-adrenal axis by dampening excessive cortisol responses to stress. It appears to normalise HPA reactivity rather than simply suppress it, which sets it apart from cortisol-blocking drugs. It also helps normalise LH pulsatility, pointing to broader neuroendocrine regulatory functions. - Q: Is DSIP structurally stable? A: DSIP is notoriously difficult to handle because it tends to cross-link and polymerise in solution. Reconstitute to low concentrations, avoid acidic conditions and repeated freeze-thaw cycling, store the lyophilised powder at 2-8°C, and use the reconstituted solution promptly. **Referenced studies:** - DSIP: a survey of 20 years of research, Experientia, 1994 (https://pubmed.ncbi.nlm.nih.gov/8036936/) - Effects of DSIP on stress and sleep in humans, Peptides, 1988 (https://pubmed.ncbi.nlm.nih.gov/2894432/) - DSIP modulates cortisol secretion and HPA reactivity, Regul Pept, 1989 (https://pubmed.ncbi.nlm.nih.gov/2475052/) ### Epitalon URL: https://milo-lab.com/products/epitalon/ Epitalon (epithalon) is a synthetic Ala-Glu-Asp-Gly tetrapeptide studied for telomerase activation, pineal regulation and longevity research. **Mechanism:** Epitalon is a four-amino-acid peptide (Ala-Glu-Asp-Gly) that upregulates expression of telomerase reverse transcriptase (hTERT), the catalytic enzyme that rebuilds telomeric DNA at chromosome ends and offsets the telomere shortening tied to cellular senescence. It interacts with chromatin and acts as a transcription modulator on genes governing cell renewal. In parallel it restores pineal gland melatonin secretion, helps normalise the hypothalamic-pituitary axis, and lowers lipid peroxidation, giving it an antioxidant profile. Animal studies report reduced age-related pathology and extended median and maximum lifespan. **FAQ:** - Q: How does epitalon activate telomerase? A: Epitalon is reported to stimulate expression of the telomerase gene (hTERT) in somatic cells that normally show little telomerase activity. Khavinson and colleagues found the peptide binds chromatin and behaves as a transcription modulator, switching on genes linked to cell renewal, so telomeres can be rebuilt rather than progressively shortened. - Q: What does epitalon do besides telomere lengthening? A: Beyond telomerase activation, epitalon restores age-related decline in pineal gland melatonin secretion, which helps re-set circadian rhythm and sleep. It also supports hypothalamic-pituitary function and reduces lipid peroxidation, an antioxidant effect. In rodent studies these actions tracked with lower spontaneous tumour incidence and longer lifespan. - Q: What is the sequence of epitalon? A: Ala-Glu-Asp-Gly, a four-amino-acid peptide and among the shortest of the bioregulators studied. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry. It is available on request before ordering. **Referenced studies:** - Geroprotective effect of epithalon in elderly subjects (randomized controlled trial), Neuro Endocrinology Letters, 2003 (https://pubmed.ncbi.nlm.nih.gov/12819699/) - Effect of Epithalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice, Biogerontology, 2002 (https://pubmed.ncbi.nlm.nih.gov/12424516/) ### GHK-Cu URL: https://milo-lab.com/products/ghk-cu/ GHK-Cu (glycyl-L-histidyl-L-lysine) is a naturally occurring copper-binding tripeptide that drives collagen synthesis, skin repair and wound healing. **Mechanism:** GHK-Cu is a tripeptide that binds a copper(II) ion, and this copper complex is what makes it biologically active. In dermal fibroblasts it upregulates synthesis of collagen types I, III and VI and boosts decorin, the proteoglycan that organises collagen fibrils into ordered structure. It triggers VEGF and FGF release to drive angiogenesis at repair sites, and it attracts macrophages and fibroblasts that clean and rebuild wounded tissue. At the transcriptional level GHK-Cu behaves as a broad gene-expression modulator: microarray work shows it switches on genes tied to tissue remodelling and antioxidant defence while switching off genes linked to inflammation and cancer progression. **FAQ:** - Q: What is GHK-Cu? A: GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper) is a naturally occurring copper peptide present in human plasma, saliva and other tissues. Plasma levels fall with age, which is why it is studied as a research agent for collagen production, skin rejuvenation and wound healing. - Q: How does GHK-Cu work? A: GHK-Cu carries a copper(II) ion that activates dermal fibroblasts to make more collagen and decorin, while signalling VEGF and FGF to grow new blood vessels at repair sites. It also acts as a gene-expression modulator, upregulating tissue-repair pathways and downregulating inflammatory ones. - Q: Why does GHK-Cu need copper to be active? A: The copper ion sets the conformation of GHK-Cu and is required for receptor binding, so free GHK without copper has much weaker activity. The copper is tightly chelated and not released as free ions under physiological conditions, which makes it safer than free copper that can generate hydroxyl radicals. - Q: What does GHK-Cu do beyond collagen? A: Microarray work by Pickart and Margolina shows GHK-Cu modulates thousands of human genes. Regulated pathways include tissue remodelling (matrix metalloproteinases and their inhibitors), inflammation (TNF-alpha and IL-6 suppression), neurological repair (NGF and BDNF upregulation) and antioxidant defence. **Referenced studies:** - GHK and GHK-Cu: Humankind's forgotten cure?, Annals of the New York Academy of Sciences, 2015 (https://pubmed.ncbi.nlm.nih.gov/26061172/) - Copper peptide GHK-Cu in collagen synthesis and wound healing, Journal of Aging Research and Clinical Practice, 2015 (https://pubmed.ncbi.nlm.nih.gov/25902313/) ### Glow 70 URL: https://milo-lab.com/products/glow-70/ Glow 70 is a 70mg repair-and-skin research blend combining BPC-157, TB-500 and GHK-Cu for tissue healing, recovery and skin quality. **Mechanism:** Glow 70 pairs three regenerative peptides in a single 70mg vial. BPC-157 (10mg) drives angiogenesis through VEGF/VEGFR2 upregulation and accelerates fibroblast migration via FAK-paxillin signalling, supporting tendon, ligament, muscle and gut-lining repair. TB-500 (10mg), a synthetic thymosin beta-4 fragment, binds free G-actin to regulate actin polymerisation, mobilising repair cells systemically and supporting new blood-vessel formation. GHK-Cu (50mg), the copper-binding tripeptide and the dominant component by mass, upregulates collagen types I, III and VI plus decorin, releases VEGF and FGF at repair sites, and acts as an antioxidant and gene-expression modulator for skin remodelling. Together they cover the repair cascade from acute injury signalling through structural rebuilding to skin quality and collagen renewal. **FAQ:** - Q: What does each component in Glow 70 contribute? A: BPC-157 supports angiogenesis and repair of tendon, ligament, muscle and gut lining. TB-500 (thymosin beta-4) drives cell migration and systemic tissue repair and flexibility. GHK-Cu, the largest component at 50mg, supports collagen and elastin synthesis, wound remodelling and skin quality. - Q: What is Glow 70 used for in research? A: Glow 70 is studied for combined recovery and skin applications: soft-tissue and connective-tissue repair, post-injury recovery, wound remodelling, and skin regeneration and quality. The GHK-Cu-weighted ratio puts more emphasis on skin and collagen than a pure recovery stack. - Q: How does Glow 70 differ from KLOW? A: Both are repair-and-skin blends built on the same core. KLOW is an 80mg vial with BPC-157 10mg, TB-500 10mg, KPV 10mg and GHK-Cu 50mg. Glow 70 is the same blend without the KPV component, so it drops the dedicated anti-inflammatory and immune layer and focuses on tissue repair plus skin regeneration. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry. It is available on request before ordering. ### Glutathione URL: https://milo-lab.com/products/glutathione/ Glutathione (GSH) is the body's master tripeptide antioxidant, supporting cellular detoxification, skin brightening and immune defence against oxidative stress. **Mechanism:** Glutathione (GSH) is a tripeptide of glutamate, cysteine and glycine, and the most abundant antioxidant inside human cells. It works in two ways: as a direct scavenger of reactive oxygen species, and as the electron donor that glutathione peroxidase enzymes use to break down hydrogen peroxide and lipid peroxides. In the liver it drives phase II detoxification, where glutathione-S-transferases conjugate GSH to reactive toxins and electrophiles so they can be excreted. GSH also regulates immune function, including lymphocyte proliferation and natural killer cell activity. Once oxidised to GSSG, it is regenerated back to active GSH by glutathione reductase using NADPH. For skin, GSH inhibits tyrosinase and shifts melanin production from darker eumelanin toward lighter pheomelanin, which underlies its brightening effect. Cellular GSH falls with age and under chronic oxidative stress. **FAQ:** - Q: How does glutathione work as an antioxidant? A: Glutathione neutralises reactive oxygen species directly and acts as the electron donor for glutathione peroxidase enzymes, which break down hydrogen peroxide and lipid peroxides. It also fuels phase II liver detoxification by conjugating to toxins so they can be cleared. After use it is recycled from its oxidised GSSG form back to active GSH. - Q: What is the structure of glutathione? A: A tripeptide of glutamate, cysteine and glycine. The reactive thiol (-SH) group on the cysteine residue is the chemically active site. - Q: Why is it supplied as a solution rather than a capsule? A: Oral glutathione is largely hydrolysed in the gastrointestinal tract, which is why research work on systemic availability uses parenteral presentations. - Q: How should it be handled after opening? A: Glutathione is unstable once dissolved and is protected from light. The certificate of analysis states the tested period for the batch. **Referenced studies:** - Glutathione metabolism and its implications for health, Journal of Nutrition, 2009 (https://pubmed.ncbi.nlm.nih.gov/19143833/) ### HCG URL: https://milo-lab.com/products/hcg/ HCG is a glycoprotein hormone and luteinising-hormone receptor agonist, used as a reference compound in HPG-axis research. **Mechanism:** Human chorionic gonadotropin is a glycoprotein hormone whose beta subunit shares roughly 85% sequence homology with luteinising hormone (LH), letting it bind and activate the same LH/CG receptor (LHCGR) on testicular Leydig cells. Receptor activation raises intracellular cAMP and drives the steroidogenic cascade - StAR-mediated cholesterol transport into the mitochondrion, then conversion to testosterone. Because HCG carries a heavily sialylated carbohydrate structure that LH lacks, it clears far more slowly, giving a long, flat LH-like stimulus instead of the sharp pulses of endogenous LH. In gonadotropin-suppressed models this sustains intratesticular testosterone - which sits orders of magnitude above serum testosterone and is what spermatogenesis actually depends on - making HCG the standard tool for probing Leydig-cell reserve and the downstream half of the hypothalamic-pituitary-gonadal axis. **FAQ:** - Q: What is HCG? A: Human chorionic gonadotropin is a glycoprotein hormone whose beta subunit shares roughly 85% homology with luteinising hormone, allowing it to bind and activate the same LH/CG receptor on testicular Leydig cells. Because it clears far more slowly than LH, a single dose delivers a long, steady LH-like stimulus. It is studied as the standard probe of Leydig-cell function and the gonadal end of the HPG axis. - Q: How does HCG differ from luteinising hormone? A: Both bind the same receptor (LHCGR), but HCG carries a heavily sialylated carbohydrate structure that LH lacks, giving it a terminal half-life of roughly 36 hours against LH’s 20 to 30 minutes. The practical consequence is signal shape: endogenous LH arrives in sharp pulses, while HCG produces sustained receptor occupancy. That is why research protocols dose HCG every other day or a few times weekly rather than attempting to mimic LH pulsatility. - Q: What is intratesticular testosterone and why does HCG research focus on it? A: Intratesticular testosterone (ITT) is the testosterone concentration inside the testis, which is far higher than serum testosterone and is what spermatogenesis actually depends on. Coviello et al. (2005) demonstrated that low-dose HCG maintains ITT in men with testosterone-induced gonadotropin suppression, and Roth et al. (2010) showed a dose-dependent ITT response at doses as low as 15 to 125 IU every other day. Serum testosterone alone does not capture this endpoint. - Q: What is the receptor target of HCG? A: HCG binds the luteinising hormone receptor (LHCGR), a G-protein coupled receptor. Its beta subunit shares roughly 85% sequence homology with luteinising hormone, which is the basis of that cross-reactivity. - Q: How is HCG reconstituted and stored? A: HCG is supplied as a lyophilised powder. Add bacteriostatic water slowly against the vial wall rather than directly onto the powder, then swirl gently - it is a glycoprotein and shaking can denature it. Keep lyophilised vials refrigerated. Once reconstituted, store at 2 to 8 °C and protect from light. - Q: Where can I buy HCG for research? A: Milo-Lab ships HCG worldwide as a lyophilised 5000 IU vial, with a tracking number on every order and discreet dispatch from Thailand. It is supplied strictly as a research chemical for laboratory use, not for human administration. **Referenced studies:** - Human chorionic gonadotropin treatment: a viable option for management of secondary hypogonadism and male infertility, Expert Rev Endocrinol Metab, 2021 (https://pubmed.ncbi.nlm.nih.gov/33345656/) - Anabolic steroid-induced hypogonadism: diagnosis and treatment, Fertil Steril, 2014 (https://pubmed.ncbi.nlm.nih.gov/24636400/) - Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL, Int Braz J Urol, 2019 (https://pubmed.ncbi.nlm.nih.gov/31408289/) ### IGF-1 LR3 URL: https://milo-lab.com/products/igf-1-lr3/ IGF-1 LR3 (Long R3 IGF-1) is a long-acting analogue of Insulin-like Growth Factor 1 that resists IGFBP binding to drive muscle protein synthesis. **Mechanism:** IGF-1 LR3 is a synthetic analogue of Insulin-like Growth Factor 1 carrying a 13-residue N-terminal extension and a Glu3-to-Arg substitution. Together these changes sharply lower its affinity for the insulin-like growth factor binding proteins (IGFBPs), so a much larger free fraction stays active in circulation and the half-life stretches from the roughly 12 minutes of native IGF-1 to about 20 to 30 hours. The peptide binds the IGF-1 receptor (IGF-1R), a receptor tyrosine kinase, and triggers two core cascades: PI3K/Akt/mTOR, which drives ribosomal biogenesis and protein synthesis, and MAPK/ERK, which drives proliferative gene expression. The combined signal pushes muscle satellite cells to proliferate, differentiate and fuse into existing fibres, raising the anabolic capacity of the tissue. **FAQ:** - Q: What is IGF-1 LR3? A: IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) is a research peptide and modified analogue of IGF-1. An N-terminal extension and a Glu3-to-Arg substitution lower its binding to IGFBPs, so it stays active far longer than native IGF-1 and signals strongly through the IGF-1 receptor. It is supplied as a 1000mcg lyophilised vial for laboratory study of anabolic and regenerative pathways. - Q: What are satellite cells and why does IGF-1 LR3 activate them? A: Satellite cells are quiescent stem cells resident beneath the basal lamina of muscle fibres. IGF-1 LR3 binds IGF-1R on these cells and pushes them to proliferate and differentiate into myoblasts, which fuse into existing fibres and donate new nuclei. More nuclei let each fibre support a larger volume of contractile protein, which is why this response is associated with durable, not just transient, anabolic change. - Q: What do the LR3 modifications change? A: A 13-residue N-terminal extension and a Glu3-to-Arg substitution sharply lower affinity for IGF binding proteins, which is why the analogue circulates far longer than native IGF-1. - Q: How is it reconstituted? A: It is degradation-sensitive, so dilute acetic acid is used rather than plain bacteriostatic water. Swirl gently until dissolved, do not shake. **Referenced studies:** - Long-R3-IGF-I protein synthesis in muscle: in vivo studies, Growth Regul, 1994 (https://pubmed.ncbi.nlm.nih.gov/7876052/) - IGF-1 receptor signalling and muscle hypertrophy, J Appl Physiol, 2003 (https://pubmed.ncbi.nlm.nih.gov/12930784/) - Role of IGF-1 in satellite cell activation and muscle regeneration, J Endocrinol, 2000 (https://pubmed.ncbi.nlm.nih.gov/10867063/) ### Insulin Syringes 1ml (10-Pack) URL: https://milo-lab.com/products/insulin-syringes/ BD Ultra-Fine II single-use syringes: 1ml, U-100 scale, 31G x 8mm, sterile interior. Pack of 10 for laboratory use only. **FAQ:** - Q: How do I read the units on the syringe? A: The U-100 scale divides 1ml into 100 units: 1 unit = 0.01ml, 10 units = 0.1ml. To convert a dose in mcg into units, use the peptide calculator - it factors in your vial size and reconstitution volume and returns the exact unit mark. - Q: Are these suitable for reconstituting peptides? A: Yes. The 1ml barrel draws bacteriostatic water precisely, and the fine needle passes through vial stoppers. For larger reconstitution volumes you may need two draws. - Q: Can a syringe be reused? A: No. These are sterile, single-use syringes. Reuse dulls the 31G needle, breaks sterility and risks contaminating the remaining solution in the vial. - Q: Can I order syringes on their own? A: No - like bacteriostatic water, syringes are a research accessory and can only be ordered together with a peptide. - Q: How many packs do I need? A: One syringe per administration. A 10-pack covers a typical multi-week research protocol; order one pack per peptide vial as a rule of thumb. - Q: What does 31G × 8mm mean? A: The gauge (31G) describes the needle diameter - higher is finer, 31G is about 0.25mm. The 8mm is the needle length, sized for subcutaneous-depth work. ### Ipamorelin URL: https://milo-lab.com/products/ipamorelin/ Ipamorelin is a selective pentapeptide growth hormone secretagogue (GHRP) that triggers clean, pulsatile GH release without spiking cortisol or prolactin. **Mechanism:** Ipamorelin is a pentapeptide GH secretagogue that binds the ghrelin receptor (GHS-R1a) on somatotrophs in the anterior pituitary. This Gq-coupled receptor activates phospholipase C, raises intracellular calcium and drives the exocytosis of GH secretory granules. Unlike the older secretagogues GHRP-2 and GHRP-6, ipamorelin does not engage the corticotropin-releasing pathways, so it releases growth hormone without meaningfully elevating cortisol, prolactin or ACTH. The outcome is a discrete, pulsatile GH pulse that mirrors the body's natural nocturnal secretory rhythm and downstream IGF-1 production. **FAQ:** - Q: What is ipamorelin? A: Ipamorelin is a selective pentapeptide growth hormone-releasing peptide (GHRP). It binds the ghrelin receptor (GHS-R1a) in the pituitary to stimulate the body's own pulsatile release of human growth hormone (HGH). It was the first GH secretagogue shown to raise GH without significantly stimulating cortisol or prolactin. - Q: How does ipamorelin work? A: Ipamorelin activates the GHS-R1a (ghrelin) receptor on pituitary somatotrophs, which raises intracellular calcium and triggers the release of stored growth hormone. That GH pulse then drives hepatic IGF-1 production, the mediator of most downstream recovery, lean-mass and tissue-repair effects. - Q: How does combining ipamorelin with CJC-1295 work? A: They act on complementary receptors. Ipamorelin binds the ghrelin receptor (GHS-R1a) to trigger GH release, while CJC-1295 binds GHRH receptors to amplify and prolong the pulse. Used together they produce a synergistic GH release larger than either alone while staying within pulsatile, physiological patterns. - Q: Does ipamorelin cause water retention? A: Ipamorelin causes less water retention than exogenous GH or older GHRPs. Any mild fluid retention is usually attributed to the IGF-1 elevation that follows GH release rather than to ipamorelin itself. - Q: Is ipamorelin available for purchase without a prescription? A: Ipamorelin is sold by Milo-Lab exclusively as a research chemical for laboratory use, not as a prescription product. No prescription is required to order it for research purposes, and each vial is labelled accordingly. **Referenced studies:** - Ipamorelin: a new growth-hormone-releasing peptide with selectivity, J Endocrinol, 1998 (https://pubmed.ncbi.nlm.nih.gov/9849822/) - Ipamorelin, the first selective growth hormone secretagogue, Eur J Endocrinol, 1999 (https://pubmed.ncbi.nlm.nih.gov/10232825/) - Effects of ipamorelin on GH axis in rats, Growth Horm IGF Res, 1998 (https://pubmed.ncbi.nlm.nih.gov/9741829/) ### Ipamorelin + CJC-1295 Blend URL: https://milo-lab.com/products/blend-ipamorelin-cjc1295/ Ipamorelin + CJC-1295 (no DAC) is a GHRH/GHRP peptide blend that pairs two receptor pathways to amplify natural growth hormone (GH) release. **Mechanism:** This blend pairs a GHRH analogue with a selective GHRP. CJC-1295 without DAC binds the pituitary GHRH receptor, a Gs-coupled receptor, raising cAMP in somatotrophs. Ipamorelin binds the ghrelin receptor GHS-R1a, a Gq-coupled receptor signalling through phospholipase C, and is selective in that it shows little affinity for the receptors mediating cortisol and prolactin release. Both peptides clear quickly, so somatostatin tone returns between exposures and the natural pulsatile rhythm is preserved. **FAQ:** - Q: What is the Ipamorelin + CJC-1295 blend? A: It is a research peptide combination that pairs CJC-1295 without DAC, a GHRH analog, with Ipamorelin, a selective growth-hormone-releasing peptide (GHRP). Milo-Lab supplies it as a single 10mg vial containing 5mg of each peptide. Together the two peptides stimulate the pituitary through separate receptor pathways to produce a larger, still-pulsatile growth hormone release than either alone. - Q: Why is the combination more effective than either peptide alone? A: CJC-1295 acts on the GHRH receptor (Gs/cAMP) while Ipamorelin acts on the ghrelin receptor (GHS-R1a/Gq/Ca2+), two independent second-messenger systems. Activating both at once lets the signals converge on the same somatotroph, so the resulting GH pulse is greater than additive. This GHRH plus GHRP pairing is a long-standing approach in growth hormone secretagogue research. - Q: Which receptors does the blend engage? A: Two distinct ones: CJC-1295 without DAC binds the GHRH receptor, which is Gs-coupled, and ipamorelin binds the ghrelin receptor GHS-R1a, which is Gq-coupled. - Q: What are the half-lives? A: CJC-1295 without DAC around 30 minutes, ipamorelin around two hours. Both clear quickly, so somatostatin tone returns between exposures. ### Kisspeptin URL: https://milo-lab.com/products/kisspeptin/ Kisspeptin-10 is a GPR54-activating neuropeptide that drives pulsatile GnRH release, raising LH, FSH and testosterone in human reproductive research. **Mechanism:** Kisspeptin-10 is the C-terminal decapeptide of kisspeptin, the neuropeptide encoded by the KISS1 gene. It binds the GPR54 receptor (also called Kiss1R) on hypothalamic GnRH neurons with nanomolar affinity and triggers a sharp burst of GnRH into the pituitary portal circulation. That GnRH pulse drives pituitary gonadotrophs to release luteinising hormone (LH) and follicle-stimulating hormone (FSH). LH then stimulates testicular Leydig cells to synthesise testosterone, while FSH supports spermatogenesis. Because kisspeptin neurons in the arcuate nucleus act as the endogenous pulse generator of the entire hypothalamic-pituitary-gonadal (HPG) axis, kisspeptin-10 lets researchers probe the axis at its upstream control point rather than at the pituitary or gonad. **FAQ:** - Q: What is kisspeptin? A: Kisspeptin is a neuropeptide encoded by the KISS1 gene that sits at the top of the reproductive hormone axis. Kisspeptin-10, its active decapeptide fragment, binds the GPR54 receptor on hypothalamic GnRH neurons and triggers pulsatile GnRH release, which in turn drives LH, FSH and testosterone. It is studied as the master switch of the HPG axis. - Q: How does kisspeptin work in puberty and reproduction? A: Kisspeptin neurons in the arcuate nucleus (KNDy neurons) act as the master pulse generators of the reproductive axis, releasing kisspeptin in synchronised bursts that drive a GnRH pulse roughly every 60 to 90 minutes. This pulsatile rhythm is essential, because continuous GnRH instead desensitises the pituitary. Loss of GPR54 (KISS1R) function causes absent puberty and infertility. - Q: What is the difference between kisspeptin-10 and kisspeptin-54? A: Kisspeptin-54 is the full-length processed form of 54 amino acids produced in peripheral tissue. Kisspeptin-10 is the C-terminal decapeptide (residues 45 to 54), the minimum sequence needed for GPR54 binding and full biological activity. Kisspeptin-10 is preferred in research for its smaller size and equivalent receptor potency. - Q: Where can I buy kisspeptin-10 for research? A: Milo-Lab ships kisspeptin-10 worldwide as lyophilised 5mg vials, singly or in 25mg/50mg multi-vial kits. It is supplied strictly as a research chemical for laboratory use, not for human administration. **Referenced studies:** - Kisspeptin-10 stimulates LH secretion in men, J Clin Endocrinol Metab, 2005 (https://pubmed.ncbi.nlm.nih.gov/15632054/) - Kisspeptin and the hypothalamic regulation of reproduction, Endocr Rev, 2012 (https://pubmed.ncbi.nlm.nih.gov/22778175/) - Kisspeptin-10 increases sexual motivation in male volunteers, J Clin Invest, 2012 (https://pubmed.ncbi.nlm.nih.gov/23028064/) ### KLOW URL: https://milo-lab.com/products/klow/ KLOW is an all-in-one healing and skin blend combining BPC-157, TB-500, KPV and GHK-Cu for tissue repair, recovery, anti-inflammatory support and skin quality. **Mechanism:** KLOW pairs four repair-oriented peptides in a single 80mg vial. BPC-157 (10mg) promotes angiogenesis and cytoprotection, supporting tendon, ligament, muscle and gut-lining repair. TB-500 (10mg), a thymosin beta-4 fragment, upregulates actin and cell migration to drive systemic tissue repair and flexibility. KPV (10mg), the C-terminal tripeptide of alpha-MSH, delivers anti-inflammatory and immune-modulating activity, including in the gut and skin. GHK-Cu (50mg), the copper tripeptide, stimulates collagen and elastin synthesis, wound remodelling and skin regeneration. Together they cover the repair cascade from acute injury signalling through to structural rebuilding and skin quality. **FAQ:** - Q: What does each component in KLOW contribute? A: BPC-157 supports angiogenesis and repair of tendon, ligament, muscle and gut lining. TB-500 (thymosin beta-4) drives cell migration and systemic tissue repair and flexibility. KPV provides anti-inflammatory and immune-modulating activity in the gut and skin. GHK-Cu supports collagen and elastin synthesis, wound remodelling and skin quality. - Q: What is KLOW used for in research? A: KLOW is studied for combined recovery and skin applications: soft-tissue and connective-tissue repair, post-injury recovery, inflammatory and gut-barrier support, and skin regeneration and quality. The four-peptide design targets the full repair cascade rather than a single pathway. - Q: What is in the vial? A: 80 mg total across four peptides: BPC-157, TB-500, GHK-Cu and KPV, supplied as a single lyophilised presentation. - Q: How does it differ from Glow 70? A: Glow 70 is a 70 mg three-peptide presentation. KLOW adds a fourth component, so the two differ in both composition and total content. ### KPV URL: https://milo-lab.com/products/kpv/ KPV (Lys-Pro-Val) is the anti-inflammatory C-terminal tripeptide of alpha-MSH, studied for gut, skin and immune-modulating research. **Mechanism:** KPV is the three-amino-acid C-terminal fragment (Lys-Pro-Val) of alpha-melanocyte stimulating hormone (alpha-MSH), and it carries most of the parent hormone's anti-inflammatory activity in a far smaller molecule. Mechanistically, KPV downregulates pro-inflammatory cytokine output by preventing NF-kB from translocating into the cell nucleus and by dampening MAP kinase signalling cascades. In intestinal epithelial cells it antagonises the NF-kB pathway directly, which helps preserve mucosal barrier integrity during inflammatory challenge. Because the peptide can cross the blood-brain barrier, it has also been examined as a tool for studying central, microglia-driven inflammation. The net effect is a targeted anti-inflammatory signal that acts at multiple tissue sites rather than a broad immunosuppressant. **FAQ:** - Q: What is KPV? A: KPV (Lys-Pro-Val) is a research tripeptide made of the final three amino acids at the C-terminal end of alpha-melanocyte stimulating hormone (alpha-MSH). Although alpha-MSH is a 13-amino-acid hormone, studies show this short fragment keeps most of its anti-inflammatory activity, which makes KPV a compact research tool for inflammation, gut and skin models. - Q: How does KPV reduce inflammation? A: KPV works by blocking the NF-kB transcription factor from entering the cell nucleus and by quietening MAP kinase signalling, which together lower pro-inflammatory cytokine production. In intestinal epithelial cells this NF-kB suppression also helps protect the mucosal barrier, so the anti-inflammatory effect is targeted rather than broadly immunosuppressive. - Q: What is KPV researched for? A: KPV is studied mainly in inflammatory bowel models (Crohn's disease and ulcerative colitis), in skin wound healing and inflammatory skin conditions such as psoriasis, and in systemic anti-inflammatory applications. Its ability to cross the blood-brain barrier has also driven interest in neuroinflammation research. - Q: How should the vial be stored? A: Lyophilised vials are stored at -20 degrees Celsius, protected from light. After reconstitution, storage is at 2 to 8 degrees Celsius; avoid repeated freeze-thaw of the solution. **Referenced studies:** - Alpha-MSH tripeptide KPV and intestinal inflammation, Peptides, 2006 (https://pubmed.ncbi.nlm.nih.gov/16723534/) - KPV inhibits NF-kappaB activation in intestinal epithelial cells, J Pharmacol Exp Ther, 2009 (https://pubmed.ncbi.nlm.nih.gov/18824711/) - Anti-inflammatory actions of the melanocortin peptides in the skin, Exp Dermatol, 2001 (https://pubmed.ncbi.nlm.nih.gov/11502077/) - Oral KPV reduces colitis in murine models, Inflamm Bowel Dis, 2012 (https://pubmed.ncbi.nlm.nih.gov/22951327/) ### L-Carnitine URL: https://milo-lab.com/products/l-carnitine/ L-Carnitine (levocarnitine) is an amino-acid derivative that transports long-chain fatty acids into the mitochondrion for beta-oxidation. **Mechanism:** L-Carnitine is a quaternary ammonium compound synthesised endogenously from lysine and methionine, mostly in the liver and kidney. Its defining role is the carnitine shuttle, the transport system that moves long-chain fatty acids across the otherwise impermeable inner mitochondrial membrane so they can undergo beta-oxidation. Carnitine palmitoyltransferase I (CPT1) on the outer membrane conjugates acyl groups to carnitine, a translocase carries the acylcarnitine across, and CPT2 releases the fatty acid into the matrix. **FAQ:** - Q: What is L-Carnitine? A: L-Carnitine (levocarnitine) is a quaternary ammonium compound the body synthesises from the amino acids lysine and methionine. It is the active enantiomer of carnitine and its main job is the carnitine shuttle - moving long-chain fatty acids into the mitochondrion, where they are oxidised for energy. It is studied as a regulator of fat metabolism, energy production and exercise recovery. - Q: How does the carnitine shuttle work? A: Long-chain fatty acids cannot cross the inner mitochondrial membrane unaided. CPT1 conjugates a fatty acyl-CoA to carnitine, carnitine-acylcarnitine translocase carries the acylcarnitine across the membrane, and CPT2 regenerates the acyl-CoA inside the matrix for beta-oxidation. This shuttle is the rate-limiting step of long-chain fat oxidation, which is why carnitine availability can influence how much fat a muscle burns. - Q: Does this vial need reconstitution? A: No. Unlike the lyophilised peptides in the catalog, L-Carnitine is supplied as a sterile, ready-to-use 500 mg/ml aqueous solution in a 10 ml vial. No bacteriostatic water is required - you draw directly from the vial. At 500 mg/ml, a 500 mg research dose corresponds to 1 ml. - Q: What concentration is the solution supplied at? A: The vial is supplied pre-mixed at 500 mg per ml in a 10 ml presentation. Published work uses concentrations across a wide range depending on the model; the certificate of analysis states the verified content. - Q: How should L-Carnitine be stored? A: Store the vial refrigerated at 2 to 8 °C and protect it from light. Allow it to reach room temperature before drawing, and do not freeze. As an aqueous solution it should be kept sealed and used within the period indicated on the vial once opened. - Q: Where can I buy L-Carnitine for research? A: Milo-Lab ships L-Carnitine worldwide as a ready-to-use 500 mg/ml, 10 ml vial, with a tracking number on every order and discreet dispatch from Thailand. It is supplied strictly as a research chemical for laboratory use, not for human administration. **Referenced studies:** - l-Carnitine Supplementation in Recovery after Exercise, Nutrients, 2018 (https://pubmed.ncbi.nlm.nih.gov/29534031/) - L-Carnitine Tartrate Supplementation for 5 Weeks Improves Exercise Recovery in Men and Women: A Randomized, Double-Blind, Placebo-Controlled Trial, Nutrients, 2021 (https://pubmed.ncbi.nlm.nih.gov/34684429/) - Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?, Molecules, 2020 (https://pubmed.ncbi.nlm.nih.gov/31906370/) ### Melanotan 2 URL: https://milo-lab.com/products/melanotan-2/ Melanotan 2 (MT-II) is a synthetic cyclic lactam analogue of alpha-MSH with agonist activity at the MC1R, MC3R, MC4R and MC5R receptors. Research compound. **Mechanism:** Melanotan 2 is a cyclic lactam analogue of alpha-MSH, cyclo[Nle4,Asp5,D-Phe7,Lys10]-alpha-MSH(4-10), that binds four melanocortin receptors with high affinity: MC1R, MC3R, MC4R and MC5R. MC1R is expressed on melanocytes and couples to cAMP; MC3R and MC4R are central receptors involved in energy homeostasis; MC5R is expressed in exocrine tissue. The lack of receptor selectivity distinguishes it from PT-141, which was derived from the same scaffold with a narrower MC3R and MC4R profile. **FAQ:** - Q: Does Melanotan 2 produce UV-independent tanning? A: Yes. MT-II stimulates melanogenesis through MC1R independently of UV radiation because it bypasses the UV-triggered release of local alpha-MSH. Skin darkening occurs even without sun exposure, and UV light accelerates the process by additionally activating MC1R through local signalling. - Q: What receptors does Melanotan 2 bind? A: It binds four melanocortin receptors with high affinity: MC1R, MC3R, MC4R and MC5R. The absence of receptor selectivity is its defining pharmacological feature and distinguishes it from PT-141, which was derived from the same scaffold with a narrower MC3R and MC4R profile. - Q: What is its plasma half-life? A: Around 33 minutes. The cyclic lactam structure gives it greater metabolic stability than linear alpha-MSH, whose half-life is measured in minutes. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry. It is available on request before ordering. **Referenced studies:** - Melanotan II: effects on sexual function and pigmentation, Peptides, 2000 (https://pubmed.ncbi.nlm.nih.gov/11060516/) - MC4R mediates the sexual and appetite effects of Melanotan II, Science, 1998 (https://pubmed.ncbi.nlm.nih.gov/9832103/) - Melanotan II and erections: double-blind crossover study, Urology, 2000 (https://pubmed.ncbi.nlm.nih.gov/10681897/) ### MOTS-c URL: https://milo-lab.com/products/mots-c/ MOTS-c is a mitochondrial-derived peptide encoded in mitochondrial DNA that activates AMPK and is studied as an exercise mimetic for metabolic regulation. **Mechanism:** MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino-acid microprotein encoded within the mitochondrial 12S rRNA gene rather than the nuclear genome. Under metabolic stress it translocates from the mitochondria into the cytoplasm and nucleus to coordinate the cellular stress response. In the cytoplasm it inhibits the folate-methionine cycle enzyme MTHFD2, which lowers de novo purine synthesis and allows AICAR to accumulate; rising AICAR activates the AMPK energy-sensing pathway, the same master switch triggered by aerobic exercise and metformin. Once inside the nucleus, MOTS-c docks at antioxidant response elements (AREs) and drives transcription of stress-defence and metabolic genes via NRF2. Circulating MOTS-c falls with age and rises sharply after exercise, which is why it is framed as a retrograde signal that lets the mitochondrion instruct the rest of the cell. **FAQ:** - Q: What is MOTS-c? A: MOTS-c is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded inside the mitochondrial 12S rRNA gene. It acts as a hormone-like signal that activates the AMPK pathway, improves insulin sensitivity and regulates nuclear stress-response genes, which is why it is studied as a metabolic and exercise-mimetic research peptide. - Q: How does MOTS-c work? A: MOTS-c translocates from the mitochondria to the cytoplasm and nucleus during metabolic stress. In the cytoplasm it inhibits the MTHFD2 enzyme, raising AICAR levels and switching on AMPK; in the nucleus it binds antioxidant response elements to activate metabolic and stress-defence genes. - Q: Why is MOTS-c called an exercise mimetic? A: Exercise elevates circulating MOTS-c, and exogenous MOTS-c in rodent studies reproduces several exercise-linked benefits such as improved insulin sensitivity and reduced age-associated physical decline. Because it activates AMPK like aerobic training, researchers treat it as a model for exercise-mimetic pharmacology. - Q: How does MOTS-c affect insulin sensitivity? A: In rodent studies MOTS-c improves glucose uptake in skeletal muscle and the liver and counters diet-induced insulin resistance, largely through AMPK activation. Plasma MOTS-c also declines with age, paralleling the age-related drop in metabolic flexibility that researchers investigate. **Referenced studies:** - MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis, Nature Communications, 2020 (https://pubmed.ncbi.nlm.nih.gov/32571738/) - A mitochondrial microprotein MOTS-c regulates insulin sensitivity and metabolic homeostasis, Cell Metabolism, 2015 (https://pubmed.ncbi.nlm.nih.gov/25738457/) ### NAD+ URL: https://milo-lab.com/products/nad/ NAD+ (nicotinamide adenine dinucleotide) is the central redox coenzyme and a substrate for sirtuin and PARP enzymes. Research compound. **Mechanism:** NAD+ (nicotinamide adenine dinucleotide) is the oxidised redox coenzyme at the centre of cellular energy production, shuttling electrons through the mitochondrial electron transport chain to drive ATP synthesis. Beyond energy metabolism it is the obligate co-substrate for the sirtuin deacetylases (SIRT1 through SIRT7), enzymes that govern DNA repair, mitochondrial biogenesis, inflammatory signalling and stress-response gene expression. NAD+ also powers the PARP family (poly-ADP-ribose polymerases), which detect and repair single-strand DNA breaks, and is consumed by CD38 ectoenzymes. Tissue NAD+ pools fall by roughly 40 to 60 percent between young adulthood and old age, which weakens sirtuin and PARP activity and makes restoring NAD+ a core target in longevity and metabolic research. **FAQ:** - Q: How does NAD+ work in the cell? A: NAD+ cycles between its oxidised (NAD+) and reduced (NADH) forms to ferry electrons through the mitochondrial electron transport chain, enabling ATP production. The same molecule is consumed by sirtuins and PARP enzymes during DNA repair and gene regulation, so the NAD+/NADH ratio acts as a real-time sensor of a cell's energy and stress state. - Q: What are the main sirtuin targets of NAD+? A: SIRT1 regulates autophagy, inflammation and circadian rhythm. SIRT3 is the principal mitochondrial sirtuin and controls oxidative stress and fatty-acid oxidation. SIRT6 supports DNA repair and telomere maintenance. Every sirtuin requires NAD+ as a substrate, so the cellular NAD+/NADH ratio directly sets how active these enzymes can be. - Q: What is the chemical role of NAD+? A: It is the oxidised redox coenzyme that carries electrons through the mitochondrial electron transport chain, and a substrate consumed by sirtuin and PARP enzymes. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry. It is available on request before ordering. **Referenced studies:** - NAD+ metabolism and its roles in cellular processes during ageing, Nature Reviews Molecular Cell Biology, 2021 (https://pubmed.ncbi.nlm.nih.gov/33353981/) - Intravenous and oral NAD+ supplementation in a mouse model of aging, Cell Metabolism, 2015 (https://pubmed.ncbi.nlm.nih.gov/26484355/) ### Nasal Spray Bottle (Empty) URL: https://milo-lab.com/products/nasal-spray-bottle/ Empty nasal spray bottle with fine-mist pump dispensing 0.1ml per actuation. Laboratory accessory, orderable with any vial. **FAQ:** - Q: How much liquid comes out per actuation? A: The pump is metered at 0.1 ml per actuation. That fixed volume is what makes actuation-count measurement possible. - Q: How many sprays does one fill last? A: Milliliters filled × 10. A 3ml fill gives about 30 sprays, a 5ml fill about 50. - Q: How do I know how many mcg are in one spray? A: mcg per spray = total mcg in the bottle ÷ (ml filled × 10). The peptide calculator has a nasal spray mode that computes this for you and can recommend a reconstitution volume for round numbers. - Q: Which peptides are typically used with a nasal spray? A: PT-141, Semax and Selank are the peptides in our catalog most commonly studied via the intranasal route. Their product pages note nasal compatibility. - Q: How do I fill the bottle? A: Reconstitute the peptide in its vial with bacteriostatic water, then draw the solution with a syringe and transfer it into the bottle. Prime with one or two actuations before first use. - Q: What color will I receive? A: White or black, depending on current stock - the bottle and pump are otherwise identical. Color cannot be selected. - Q: Can I order the bottle on its own? A: No - like bacteriostatic water and syringes, it is a research accessory and can only be ordered together with a peptide. ### Oxytocin URL: https://milo-lab.com/products/oxytocin/ Oxytocin is a 9-amino-acid hypothalamic neuropeptide and oxytocin-receptor agonist studied for social bonding, trust, stress reduction and prosocial behaviour. **Mechanism:** Oxytocin is a nine-amino-acid cyclic neuropeptide (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly) with a disulfide bridge between the two cysteine residues, produced in the paraventricular and supraoptic nuclei of the hypothalamus. It is an agonist at the oxytocin receptor, a Gq-coupled G-protein coupled receptor signalling through phospholipase C and intracellular calcium. Peripheral oxytocin crosses the blood-brain barrier poorly, which is why central and peripheral compartments are studied separately. **FAQ:** - Q: What is oxytocin? A: Oxytocin is a nine-amino-acid cyclic neuropeptide produced in the hypothalamus, with a disulfide bridge between positions 1 and 6. It is an agonist at the oxytocin receptor, a G-protein coupled receptor. Supplied as lyophilised powder for laboratory research. - Q: What is its plasma half-life? A: Roughly one to six minutes in plasma. The short half-life reflects rapid enzymatic degradation by oxytocinase and renal clearance. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry, available on request. - Q: How should the vial be stored? A: Lyophilised at -20 degrees Celsius, protected from light; reconstituted at 2 to 8 degrees Celsius. Avoid repeated freeze-thaw of the solution. **Referenced studies:** - Intranasal oxytocin increases trust in humans, Nature, 2005 (https://pubmed.ncbi.nlm.nih.gov/15931222/) - Oxytocin reduces amygdala responses to social threats, Proc Natl Acad Sci USA, 2011 (https://pubmed.ncbi.nlm.nih.gov/21642543/) - Intranasal oxytocin in autism spectrum disorders: RCT, Mol Autism, 2013 (https://pubmed.ncbi.nlm.nih.gov/23203893/) ### Pinealon URL: https://milo-lab.com/products/pinealon/ Pinealon (Glu-Asp-Arg, EDR) is a Khavinson short-peptide bioregulator studied for neuroprotection, melatonin support and reduced neuronal oxidative stress. **Mechanism:** Pinealon is a synthetic tripeptide (Glu-Asp-Arg, the EDR sequence) belonging to the Khavinson family of short-peptide bioregulators derived from pineal gland sequences. Because it is small enough to cross the cell and nuclear membranes, EDR reaches the genome directly and binds promoter regions of pineal-relevant genes, acting as a transcriptional switch rather than a receptor ligand. It up-regulates arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme of melatonin synthesis, and Nrf2-controlled antioxidant genes such as heme oxygenase-1, superoxide dismutase and catalase. By raising antioxidant capacity and supporting survival genes of the Bcl-2 family, Pinealon lowers oxidative stress-induced apoptosis and reduces the build-up of lipofuscin in post-mitotic neurons, two processes central to brain aging. **FAQ:** - Q: What is Pinealon? A: Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg (EDR), one of the Khavinson short-peptide bioregulators derived from pineal gland sequences. In research it is studied as a gene-regulating neuroprotective peptide that supports melatonin-related pathways and lowers neuronal oxidative stress. - Q: How does Pinealon work in the brain? A: Being a short three-amino-acid peptide, EDR enters cells and the nucleus and binds promoter regions of target genes. It up-regulates AANAT (the rate-limiting enzyme for melatonin synthesis) and Nrf2-controlled antioxidant enzymes, while supporting Bcl-2 survival genes. The net research effect is higher antioxidant capacity and less oxidative apoptosis in neurons. - Q: How does Pinealon affect melatonin? A: Pinealon activates transcription of melatonin-biosynthesis genes, in particular arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme of melatonin production. Because pineal output declines with age, EDR is studied for its potential to partially restore melatonin synthesis by supporting the gland's transcriptional activity. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry. It is available on request before ordering. **Referenced studies:** - Pineal gland peptides and brain aging, Ann N Y Acad Sci, 2004 (https://pubmed.ncbi.nlm.nih.gov/15349960/) - EDR tripeptide reduces lipofuscin and neuronal apoptosis, Bull Exp Biol Med, 2007 (https://pubmed.ncbi.nlm.nih.gov/17987296/) - Peptide bioregulators of pineal gland and neurological function, Neuro Endocrinol Lett, 2007 (https://pubmed.ncbi.nlm.nih.gov/17949283/) ### PT-141 URL: https://milo-lab.com/products/pt-141/ PT-141 (bremelanotide) is a melanocortin MC4R agonist peptide that acts centrally in the brain to drive sexual desire and arousal. **Mechanism:** PT-141 (bremelanotide) is a cyclic heptapeptide analogue of alpha-MSH that activates the melanocortin receptors MC3R and MC4R in the hypothalamus. Where PDE5 inhibitors such as sildenafil and tadalafil act peripherally on vascular smooth muscle to improve blood flow, PT-141 engages the central dopaminergic reward circuitry that governs sexual motivation. MC4R activation in the medial preoptic area increases dopamine release in the nucleus accumbens and recruits oxytocin neurons in the paraventricular nucleus, so desire itself is increased rather than just the physical response. This central, arousal-independent pathway is why bremelanotide works in the absence of prior stimulation. **FAQ:** - Q: What is PT-141? A: PT-141 (bremelanotide) is a melanocortin receptor agonist peptide, a cyclic heptapeptide analogue of alpha-MSH that activates MC3R and MC4R in the hypothalamus. Unlike PDE5 inhibitors, it acts centrally in the brain to increase sexual desire and arousal in both male and female research, independent of vascular function. The FDA approved it as Vyleesi in 2019. - Q: How is PT-141 different from Viagra or Cialis? A: PDE5 inhibitors (Viagra, Cialis) work peripherally by increasing cGMP in vascular smooth muscle, improving blood flow to genital tissue. They require sexual stimulation to work and do not affect desire. PT-141 works centrally in the brain via MC4R, directly increasing dopaminergic signalling in the reward circuits governing sexual motivation - affecting desire itself, not just physical response. It works in the absence of prior arousal. - Q: What receptors does PT-141 bind? A: The melanocortin receptors MC3R and MC4R, acting centrally in the hypothalamus. That is a different point of action from PDE5 inhibitors, which work peripherally on vascular smooth muscle. - Q: What is its half-life? A: Around 2.7 hours. It is a cyclic heptapeptide analogue of alpha-MSH. **Referenced studies:** - Bremelanotide for female hypoactive sexual desire disorder, Obstet Gynecol, 2019 (https://pubmed.ncbi.nlm.nih.gov/31251464/) - PT-141: a melanocortin agonist for the treatment of sexual dysfunction, Ann N Y Acad Sci, 2003 (https://pubmed.ncbi.nlm.nih.gov/12764128/) - MC4R and sexual function: central mechanisms, J Sex Med, 2006 (https://pubmed.ncbi.nlm.nih.gov/16413024/) ### Retatrutide URL: https://milo-lab.com/products/retatrutide/ Retatrutide (LY3437943) is an investigational peptide binding the GLP-1, GIP and glucagon receptors. Research compound, not an approved medicine. **Mechanism:** Retatrutide is a single peptide with agonist activity at three receptors: GLP-1, GIP and glucagon. GLP-1 and GIP are incretin receptors, both class B G-protein coupled receptors signalling through cAMP. The glucagon receptor is the third target and distinguishes retatrutide from dual agonists such as tirzepatide and from single GLP-1 agonists such as semaglutide. Its plasma half-life of roughly six days derives from fatty-acid acylation and reversible albumin binding. **FAQ:** - Q: What is retatrutide? A: Retatrutide (development code LY3437943) is an investigational peptide from Eli Lilly that binds three receptors: GLP-1, GIP and glucagon. It is supplied as a lyophilised powder for laboratory research and is not an approved medicine in any jurisdiction. - Q: What is its receptor profile compared with semaglutide and tirzepatide? A: Semaglutide is a single GLP-1 receptor agonist, tirzepatide binds GLP-1 and GIP, and retatrutide adds glucagon receptor binding as a third target. The comparison describes receptor affinity only, not outcomes. - Q: How is retatrutide supplied and verified? A: As lyophilised powder in sealed vials. Each batch ships with a certificate of analysis stating purity by HPLC and identity by mass spectrometry. The certificate is available on request before ordering. - Q: How should the vial be stored? A: Lyophilised vials are stored at -20 degrees Celsius, protected from light. After reconstitution with bacteriostatic water, storage is at 2 to 8 degrees Celsius. Avoid repeated freeze-thaw of the reconstituted solution. **Referenced studies:** - Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes (phase 2), The Lancet, 2023 (https://pubmed.ncbi.nlm.nih.gov/37385278/) - Triple-hormone-receptor agonist retatrutide for obesity (phase 2), New England Journal of Medicine, 2023 (https://pubmed.ncbi.nlm.nih.gov/37385285/) ### Selank URL: https://milo-lab.com/products/selank/ Selank is a synthetic tuftsin-analogue heptapeptide developed in Russia, studied as a non-sedating anxiolytic and nootropic that raises BDNF. **Mechanism:** Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic analogue of the endogenous immunomodulatory peptide tuftsin, extended with a Pro-Gly-Pro sequence that resists enzymatic breakdown. It modulates GABAergic transmission without binding the benzodiazepine allosteric site, so anxiolysis occurs without sedation. In parallel it upregulates BDNF and GDNF expression in the hippocampus and frontal cortex, lowers noradrenaline turnover in the locus coeruleus to dampen hyperarousal, and shifts serotonin uptake and metabolism in limbic structures. Because it does not act as a direct GABA-A agonist, it carries no tolerance, withdrawal, or dependence profile, which separates it mechanistically from benzodiazepine anxiolytics. **FAQ:** - Q: What is Selank? A: Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a stabilised analogue of the immune peptide tuftsin, studied as a non-sedating anxiolytic and nootropic. Milo-Lab supplies it as lyophilised 5mg research vials. - Q: How does Selank work? A: Selank modulates GABAergic transmission without binding the benzodiazepine site, which produces calm without drowsiness. At the same time it raises BDNF and GDNF expression in the hippocampus and frontal cortex, lowers noradrenaline turnover in the locus coeruleus, and adjusts serotonin metabolism in limbic regions. The combined effect supports both anxiolytic and cognitive endpoints. - Q: What does BDNF upregulation by Selank mean for cognition? A: Brain-derived neurotrophic factor (BDNF) drives long-term potentiation, the synaptic strengthening behind learning and memory. Selank increases BDNF mRNA and protein in the hippocampus and frontal cortex. Higher BDNF levels are linked to better memory consolidation and are an active research target in depression and cognitive impairment. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry. It is available on request before ordering. **Referenced studies:** - Selank modulates anxiety and BDNF expression, Bull Exp Biol Med, 2007 (https://pubmed.ncbi.nlm.nih.gov/18078019/) - Anxiolytic and nootropic effects of Selank in clinical trials, Bull Exp Biol Med, 2009 (https://pubmed.ncbi.nlm.nih.gov/19370746/) - Selank and Semax: neuropeptide anxiolytics developed in Russia, Curr Pharm Des, 2008 (https://pubmed.ncbi.nlm.nih.gov/18188620/) ### Semaglutide URL: https://milo-lab.com/products/semaglutide/ Semaglutide is a 31-amino-acid GLP-1 receptor agonist peptide with C18 fatty-acid acylation. Research compound, supplied as lyophilised powder. **Mechanism:** Semaglutide is a modified GLP-1 analogue carrying a C18 fatty-acid chain bound through a linker to lysine at position 34, with an alpha-aminoisobutyric acid substitution at position 8 that resists DPP-4 cleavage. The acylation drives reversible albumin binding, which extends plasma half-life to roughly seven days. It is a selective agonist at the GLP-1 receptor, a class B G-protein coupled receptor signalling through cAMP, expressed in pancreatic islets and in several central nervous system regions. **FAQ:** - Q: What is semaglutide? A: Semaglutide is a 31-amino-acid GLP-1 receptor agonist peptide with a C18 fatty-acid side chain that extends plasma half-life through albumin binding. Supplied as lyophilised powder for laboratory research. - Q: What is its half-life and why? A: Around seven days. The fatty-acid modification promotes reversible albumin binding, which slows renal clearance and enzymatic degradation compared with native GLP-1. - Q: How is purity verified? A: Each batch ships with a certificate of analysis reporting purity by HPLC and identity by mass spectrometry, available on request before ordering. - Q: How should the vial be stored? A: Lyophilised at -20 degrees Celsius, protected from light; reconstituted at 2 to 8 degrees Celsius. Avoid repeated freeze-thaw cycles of the solution. **Referenced studies:** - Once-weekly semaglutide in adults with overweight or obesity (STEP-1), New England Journal of Medicine, 2021 (https://pubmed.ncbi.nlm.nih.gov/33567185/) - Semaglutide and cardiovascular outcomes in patients with type 2 diabetes (SUSTAIN-6), New England Journal of Medicine, 2016 (https://pubmed.ncbi.nlm.nih.gov/27633186/) ### Semax URL: https://milo-lab.com/products/semax/ Semax is a synthetic ACTH(4-7) heptapeptide nootropic that upregulates BDNF and NGF for cognitive enhancement and neuroprotection. **Mechanism:** Semax is a synthetic heptapeptide built on the ACTH(4-7) fragment (Met-Glu-His-Phe) and extended with a Pro-Gly-Pro tail that resists enzymatic breakdown. Stripping the rest of the adrenocorticotropic hormone removes its cortisol-releasing action while keeping the neurotrophic signalling intact, so Semax raises brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) through melanocortin-receptor-independent pathways. It also lifts dopaminergic and serotonergic tone, boosts vascular endothelial growth factor (VEGF) in neurons and astrocytes, and lowers oxidative-stress markers after ischaemic injury. The combined effect supports synaptic plasticity for cognition and protects neurons in low-oxygen conditions. **FAQ:** - Q: What is Semax? A: Semax is a synthetic heptapeptide nootropic developed by the Russian Academy of Sciences in the 1990s. Based on the ACTH(4-7) fragment and stabilised with a Pro-Gly-Pro tail, it raises BDNF and NGF to support cognition and protect neurons. It is registered in Russia for ischaemic stroke and used in research as a cognitive enhancer and neuroprotectant. - Q: What is the relationship between Semax and ACTH? A: Semax is derived from ACTH(4-7), the fragment of adrenocorticotropic hormone responsible for its memory-enhancing and neuroprotective effects. The full ACTH molecule also triggers cortisol release from the adrenal cortex. By using only the 4-7 fragment and extending it with Pro-Gly-Pro, Semax keeps the neurotrophic activity without the adrenal stimulation. - Q: Is Semax approved anywhere? A: Semax has been registered in Russia since 1996 for ischaemic stroke, dyscirculatory encephalopathy, and as a cognitive enhancer, and is available there by prescription as a nasal spray. Outside Russia it is an unapproved research compound and is sold for laboratory use only. - Q: How should the vial be stored? A: Lyophilised vials are stored at -20 degrees Celsius, protected from light. After reconstitution, storage is at 2 to 8 degrees Celsius; avoid repeated freeze-thaw of the solution. **Referenced studies:** - Semax increases BDNF and NGF expression in rat brain, Bull Exp Biol Med, 2006 (https://pubmed.ncbi.nlm.nih.gov/16879178/) - Clinical use of Semax in acute ischaemic stroke, Zh Nevrol Psikhiatr Im S S Korsakova, 2001 (https://pubmed.ncbi.nlm.nih.gov/11338769/) - Semax and cognitive function in children with ADHD, Zh Nevrol Psikhiatr Im S S Korsakova, 2004 (https://pubmed.ncbi.nlm.nih.gov/14714879/) ### Sermorelin URL: https://milo-lab.com/products/sermorelin/ Sermorelin (GRF 1-29) is a synthetic GHRH-analogue peptide that stimulates the pituitary to release growth hormone in natural, pulsatile rhythm. **Mechanism:** Sermorelin reproduces GHRH(1-29)-NH2, the active 29-amino-acid N-terminal fragment of the 44-residue growth hormone-releasing hormone. It binds the GHRH receptor (GHRHR) on anterior-pituitary somatotrophs as a full agonist, coupling through the Gs protein to activate adenylyl cyclase and raise intracellular cAMP. This signal drives transcription of the GH gene and triggers pulsatile growth-hormone secretion. Because sermorelin is the endogenous GHRH sequence rather than a long-acting analogue, its release of GH stays subject to somatostatin (SRIF) feedback, so the pituitary keeps its native pulse pattern and is not driven toward continuous, unregulated GH output. **FAQ:** - Q: What is sermorelin? A: Sermorelin (also called GRF 1-29 or GHRH 1-29) is a synthetic peptide that copies the first 29 amino acids of human growth hormone-releasing hormone. It binds the GHRH receptor on the pituitary and prompts the gland to secrete its own growth hormone in natural pulses, which is why it is studied as a GH secretagogue rather than as exogenous HGH. - Q: How does sermorelin work? A: Sermorelin acts as a full agonist at the pituitary GHRH receptor. Binding activates the Gs/adenylyl-cyclase/cAMP pathway in somatotroph cells, increasing GH gene expression and releasing stored growth hormone. Because it works upstream at the pituitary, GH output remains gated by the body's own somatostatin feedback. - Q: What is the advantage of sermorelin over GHRH analogues like CJC-1295? A: Sermorelin has the longest research track record of any GHRH peptide and was originally approved (as Geref) for GH-deficiency testing in children. Because it is the native GHRH(1-29) sequence, it acts in harmony with somatostatin rhythms and is less likely to override the body's GH feedback. For the most physiological GHRH stimulus, sermorelin is the reference compound. - Q: Why does sermorelin have such a short half-life? A: Native GHRH(1-29) is cleaved rapidly by DPP-IV at the Ala2 position and by other endopeptidases. The short half-life (~7-12 minutes) mirrors the brief, pulsatile GHRH bursts the hypothalamus normally releases, and that pulsatility helps preserve pituitary sensitivity. Long-acting analogues like CJC-1295 extend the half-life at the cost of some physiological specificity. - Q: How does sermorelin interact with somatostatin? A: Somatostatin (SRIF) is the natural inhibitor of GH release. Sermorelin works within that existing rhythm: when somatostatin tone is high its stimulation is blunted, and when tone is low it produces robust GH pulses. This feedback-preserving behaviour is considered an advantage over longer-acting analogues that override somatostatin regulation. **Referenced studies:** - Sermorelin: clinical pharmacology review, Endocr Rev, 1997 (https://pubmed.ncbi.nlm.nih.gov/9054957/) - Sermorelin in adult GH deficiency: a controlled trial, J Clin Endocrinol Metab, 1996 (https://pubmed.ncbi.nlm.nih.gov/8567019/) - Sermorelin and the aging GH axis, Endocr Rev, 1997 (https://pubmed.ncbi.nlm.nih.gov/9054957/) ### SLU-PP-332 URL: https://milo-lab.com/products/slu-pp-332/ SLU-PP-332 is an estrogen-related receptor (ERR) pan-agonist studied as an exercise mimetic that boosts mitochondrial activity and fat oxidation. **Mechanism:** SLU-PP-332 is a synthetic small-molecule agonist of the estrogen-related receptors ERR alpha, ERR beta and ERR gamma, orphan nuclear receptors that regulate transcription of genes in oxidative metabolism. Receptor activation upregulates transcriptional programmes associated with mitochondrial biogenesis and fatty-acid oxidation. It acts through nuclear-receptor transcription rather than through cell-surface receptor signalling, which distinguishes its mechanism from that of the incretin peptides. **FAQ:** - Q: How does SLU-PP-332 work as an exercise mimetic? A: By switching on the ERR family, SLU-PP-332 amplifies the PGC-1 alpha pathway that muscles normally activate during endurance training. This promotes mitochondrial biogenesis and a metabolic shift toward burning fat for fuel, reproducing key adaptations of aerobic exercise at the transcriptional level. - Q: What class of compound is SLU-PP-332? A: A synthetic small molecule, not a peptide. It is an agonist of the estrogen-related receptors ERR alpha, ERR beta and ERR gamma, orphan nuclear receptors that regulate transcription. - Q: How does its mechanism differ from the incretin peptides? A: It acts through nuclear-receptor transcription inside the cell rather than through cell-surface receptor signalling. That is a fundamentally different point of action. - Q: What is its half-life? A: Approximately one to three hours in published pharmacokinetic work. ### Somatropin URL: https://milo-lab.com/products/somatropin/ Somatropin is recombinant 191-amino-acid human growth hormone (rHGH), the reference compound for growth hormone receptor and IGF-1 axis research. **Mechanism:** Somatropin is recombinant human growth hormone, identical in sequence to the 191-amino-acid hormone produced by the pituitary gland. It binds the growth-hormone receptor (GHR) on target cells, dimerising the receptor and activating the JAK2/STAT5 pathway. Signalling proceeds along two routes: directly through the GHR on peripheral tissue, and indirectly through hepatic IGF-1 expression, which mediates a large part of the downstream transcriptional response. **FAQ:** - Q: What is somatropin? A: Somatropin is recombinant human growth hormone (rHGH): a 191-amino-acid polypeptide with the same sequence as endogenous pituitary GH, produced by recombinant DNA technology and supplied as a lyophilised powder for research reconstitution. - Q: How is somatropin different from GH secretagogues like ipamorelin? A: Secretagogues stimulate the pituitary to release its own GH in natural pulses. Somatropin is the growth hormone itself, delivered directly - giving researchers precise control over dose and timing rather than relying on endogenous release. - Q: How should somatropin be reconstituted and stored? A: Reconstitute with bacteriostatic water added slowly against the vial wall, then swirl gently - never shake, as HGH is a fragile protein. Store lyophilised vials refrigerated; keep reconstituted solution at 2-8 °C, protected from light. - Q: What does 100iu mean? A: The kit contains 100 international units of somatropin total, supplied as 10 vials of 10iu each. IU is the standard unit of measure for growth hormone. - Q: Where can researchers buy somatropin in Thailand? A: Milo-Lab ships research-grade somatropin from Bangkok with discreet, fast domestic and international delivery. All products are supplied strictly for laboratory research use only. **Referenced studies:** - Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials, Pituitary, 2015 (https://pubmed.ncbi.nlm.nih.gov/24810900/) - Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications, Endocr Rev, 2025 (https://pubmed.ncbi.nlm.nih.gov/40718994/) - Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial, J Clin Endocrinol Metab, 2020 (https://pubmed.ncbi.nlm.nih.gov/32022863/) ### SS-31 URL: https://milo-lab.com/products/ss-31/ SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide that binds cardiolipin to restore ATP output and reduce oxidative stress in aged cells. **Mechanism:** SS-31, also catalogued as MTP-131 and elamipretide, is a small cell-permeable tetrapeptide that accumulates roughly 1000-fold inside the inner mitochondrial membrane, where it selectively binds cardiolipin, a phospholipid found almost nowhere else in the cell. By anchoring to cardiolipin, SS-31 protects the lipid from peroxidation and preserves its interaction with cytochrome c, which keeps cristae junctions tightly folded and holds the electron transport chain supercomplexes in their efficient arrangement. The downstream effects are higher mitochondrial ATP synthesis, less electron leak from complexes I and III, lower reactive oxygen species (ROS) generation at the source, and resistance to mitochondrial permeability transition pore opening during ischaemia and reperfusion. **FAQ:** - Q: What is SS-31? A: SS-31 (also known as elamipretide or MTP-131) is a mitochondria-targeted research tetrapeptide that concentrates in the inner mitochondrial membrane and binds cardiolipin. By stabilising cardiolipin it restores electron transport chain efficiency, raises ATP output and lowers oxidative stress, which is why it is studied in mitochondrial dysfunction, cardiac and age-related decline models. - Q: How does SS-31 work in mitochondria? A: SS-31 accumulates around 1000-fold inside the inner mitochondrial membrane and binds cardiolipin, a phospholipid unique to that membrane. This binding keeps cristae junctions organised and holds the electron transport chain supercomplexes together, so ATP synthesis improves while electron leak and ROS production fall. SS-31 acts without needing to enter the mitochondrial matrix. - Q: What is cardiolipin and why does SS-31 target it? A: Cardiolipin is a dimeric phospholipid found almost exclusively in the inner mitochondrial membrane and is essential for electron transport chain supercomplex assembly, cristae junction formation and cytochrome c binding. Cardiolipin abundance and integrity decline with ageing and heart failure, which destabilises mitochondrial function. SS-31 binds cardiolipin directly and helps restore those supercomplexes. - Q: How should the vial be stored? A: Lyophilised vials are stored at -20 degrees Celsius, protected from light. After reconstitution, storage is at 2 to 8 degrees Celsius; avoid repeated freeze-thaw of the solution. **Referenced studies:** - Elamipretide (MTP-131), a novel cardiolipin-targeting peptide, improves mitochondrial structure and function in dogs with heart failure, Circulation: Heart Failure, 2015 (https://pubmed.ncbi.nlm.nih.gov/25681484/) - SS-31 rejuvenates aged mitochondrial ultrastructure, kinetics and respiration by binding to cardiolipin, Communications Biology, 2020 (https://pubmed.ncbi.nlm.nih.gov/32764534/) ### TB-500 URL: https://milo-lab.com/products/tb-500/ TB-500 is a synthetic Thymosin Beta-4 fragment, a regenerative research peptide that drives systemic tissue repair via actin regulation. **Mechanism:** TB-500 reproduces the active region of Thymosin Beta-4 (TB4), a 43-amino-acid peptide expressed in almost every cell type. Its core function is binding free G-actin monomers, which fine-tunes actin polymerisation and lets cells migrate quickly toward sites of injury. Through this actin-regulating activity TB-500 mobilises repair cells systemically, increases expression of growth-factor receptors, and supports new blood-vessel formation (angiogenesis) by upregulating matrix metalloproteinases such as MMP-2. It also dampens local inflammation, with research linking Thymosin Beta-4 to reduced NF-kB signalling and lower pro-inflammatory cytokine output. Unlike locally acting compounds, TB-500 circulates and acts body-wide, which makes it a reference peptide for soft-tissue, cardiac and wound-healing models. **FAQ:** - Q: What is TB-500? A: TB-500 is a synthetic research peptide that reproduces the active region of Thymosin Beta-4, a naturally occurring repair protein. It works systemically by regulating actin and mobilising cells to damaged tissue, making it a widely studied compound for soft-tissue, cardiac and wound-healing research. Milo-Lab supplies it as research-grade lyophilised vials in 10mg, 25mg and 50mg formats. - Q: What distinguishes TB-500 from BPC-157? A: TB-500 is a synthetic fragment of Thymosin Beta-4 that acts systemically via actin regulation and cell migration. BPC-157 is derived from gastric protein and acts more locally via angiogenesis and the FAK pathway. They complement each other: TB-500 mobilises repair cells throughout the body, BPC-157 drives vascular and fibroblast activity at the injury site. - Q: Is TB-500 the same as Thymosin Beta-4? A: TB-500 is a synthetic fragment corresponding to the key active region of Thymosin Beta-4 (amino acids 17-23: LKKTETQ). It is not the full Thymosin Beta-4 molecule (43 amino acids), but research suggests the fragment retains the primary biological activity of the full protein at a lower molecular weight. - Q: Can TB-500 be used for cardiac research? A: Yes, cardiac repair is one of the most-studied applications. Multiple studies have found Thymosin Beta-4 promotes epicardial progenitor cell mobilisation and cardiomyocyte survival after ischaemic injury. TB-500 is the research-grade form used to study these effects. - Q: Where can researchers buy TB-500 5mg vials? A: Milo-Lab supplies TB-500 as a research-grade 10mg single vial or 25mg/50mg multi-vial kits, shipped worldwide. It is also available paired with BPC-157 for combined repair-pathway research; see the [BPC-157 vs TB-500 comparison](/compare/bpc-157-vs-tb-500). **Referenced studies:** - Thymosin beta4 and cardiac repair, Ann N Y Acad Sci, 2004 (https://pubmed.ncbi.nlm.nih.gov/15778519/) - Thymosin beta-4 promotes oligodendrocyte differentiation and myelination, J Neurosci, 2009 (https://pubmed.ncbi.nlm.nih.gov/19110467/) - Thymosin beta 4 promotes dermal healing, J Invest Dermatol, 2000 (https://pubmed.ncbi.nlm.nih.gov/10698571/) - TB4 mobilises endothelial progenitor cells for cardiac repair, Nat Clin Pract Cardiovasc Med, 2007 (https://pubmed.ncbi.nlm.nih.gov/17717067/) ### Tesamorelin URL: https://milo-lab.com/products/tesamorelin/ Tesamorelin is a synthetic GHRH(1-44) analogue with an N-terminal trans-3-hexenoyl group that resists DPP-4 cleavage. Research compound. **Mechanism:** Tesamorelin is a stabilised analogue of full-length GHRH(1-44), carrying a trans-3-hexenoic acid group on its N-terminus that blocks DPP-IV cleavage and lengthens the circulating half-life to roughly half an hour. It binds the GHRH receptor on pituitary somatotrophs with high affinity and triggers pulsatile growth hormone secretion, which in turn raises hepatic IGF-1 output. The released growth hormone acts on visceral adipocytes through the GH receptor and JAK2-STAT5 signalling, activating hormone-sensitive lipase and increasing lipolysis. Because it amplifies the body's own GHRH pulse rather than supplying exogenous GH, the resulting hormone profile stays physiological and feedback-regulated. Phase 3 trials confirmed marked reduction of visceral adipose tissue (VAT) through this growth-hormone-driven lipolytic pathway. **FAQ:** - Q: What is tesamorelin? A: Tesamorelin is a synthetic analogue of growth hormone releasing hormone, GHRH(1-44), stabilised at the N-terminus against dipeptidyl peptidase-4 cleavage. Supplied as lyophilised powder for laboratory research. - Q: How does it differ from sermorelin? A: Sermorelin is the GHRH(1-29) fragment. Tesamorelin carries the full 44-amino-acid sequence with a trans-3-hexenoyl group at the N-terminus, which slows enzymatic degradation. The difference is structural. - Q: What is its plasma half-life? A: Roughly 26 to 38 minutes in published pharmacokinetic work, consistent with the short half-life typical of GHRH analogues. - Q: How should the vial be stored? A: Lyophilised at -20 degrees Celsius, protected from light; reconstituted at 2 to 8 degrees Celsius, used within the period stated on the certificate. **Referenced studies:** - Tesamorelin reduces visceral adipose tissue in HIV patients, J Acquir Immune Defic Syndr, 2010 (https://pubmed.ncbi.nlm.nih.gov/20107226/) - Tesamorelin improves cognition in older adults with mild cognitive impairment, J Clin Endocrinol Metab, 2019 (https://pubmed.ncbi.nlm.nih.gov/31358994/) - Tesamorelin phase 3 clinical trials: FDA review, N Engl J Med, 2010 (https://pubmed.ncbi.nlm.nih.gov/20683248/) ### Tesofensine URL: https://milo-lab.com/products/tesofensine/ Tesofensine (NS2330) is an orally available triple monoamine reuptake inhibitor at the DAT, NET and SERT transporters. Research compound. **Mechanism:** Tesofensine (development code NS2330) is a centrally-acting triple monoamine reuptake inhibitor that blocks the presynaptic transporters for noradrenaline (NET), dopamine (DAT) and serotonin (SERT). Blocking reuptake raises the synaptic concentration of all three monoamines. It was originally developed as a candidate for Parkinson's and Alzheimer's disease. Its plasma half-life of roughly nine days is among the longest in this compound class. Unlike the incretin peptides it is a small molecule and orally available. **FAQ:** - Q: What is tesofensine? A: Tesofensine (development code NS2330) is a small-molecule triple monoamine reuptake inhibitor acting at the dopamine, noradrenaline and serotonin transporters. It is supplied in capsule form for laboratory research, not as a peptide. - Q: What is its half-life? A: Approximately nine days in published pharmacokinetic studies, among the longest of the monoamine reuptake inhibitors. - Q: How is it supplied and verified? A: In sealed capsules at the stated content per unit, with a certificate of analysis reporting purity and identity, available on request before ordering. - Q: How should it be stored? A: Sealed, dry, at room temperature and protected from light and humidity. No reconstitution is required. **Referenced studies:** - Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial, The Lancet, 2008 (https://pubmed.ncbi.nlm.nih.gov/18950853/) ### Thymosin Alpha-1 URL: https://milo-lab.com/products/thymosin-alpha-1/ Thymosin Alpha-1 (Ta1) is a 28-amino-acid thymic immunomodulator peptide that activates TLR2/TLR9 signalling to prime innate and T-cell immunity. **Mechanism:** Thymosin Alpha-1 (Ta1) is a 28-amino-acid acetylated peptide first isolated from thymosin fraction 5 of thymus tissue, and it is the best characterised thymic immunomodulator in immunological research. Ta1 engages innate immunity by acting as a Toll-like receptor agonist: it binds TLR2 and TLR9 on dendritic cells and macrophages, triggering MyD88 to NF-kB signalling that drives interleukin-12 (IL-12) and type I interferon production. Beyond innate priming, Ta1 supports adaptive immunity by promoting thymic T-cell maturation, steering naive T-cells toward Th1 effector differentiation, and raising natural killer (NK) cell cytotoxicity. Because it restores a coordinated, pathogen-like immune response rather than blunt non-specific activation, Ta1 is studied across antiviral, oncology and immunosenescence contexts. **FAQ:** - Q: How does Thymosin Alpha-1 work? A: Ta1 binds Toll-like receptors TLR2 and TLR9 on dendritic cells and macrophages, driving MyD88 to NF-kB signalling that produces IL-12 and type I interferons. In parallel it promotes T-cell maturation, Th1 effector differentiation and natural killer cell cytotoxicity, producing a coordinated innate and adaptive immune response. - Q: How does Ta1 differ from other immunostimulants? A: Most immunostimulants such as beta-glucans or LPS activate immune cells non-specifically. Ta1 works through TLR2 and TLR9, pattern-recognition receptors that detect bacterial and viral nucleic-acid motifs. The result is a coordinated innate response with IL-12 and interferon production, mirroring a genuine pathogen encounter rather than blunt activation. - Q: What does pharmaceutical approval in 35+ countries mean for Ta1? A: Thymosin Alpha-1 (Zadaxin, SciClone Pharmaceuticals) holds full pharmaceutical approval in over 35 countries including Italy, Singapore, China and Egypt for hepatitis B, hepatitis C and as a cancer vaccine adjuvant. In the US and EU it remains investigational and research-use-only, though it has received FDA Fast Track and Orphan Drug designations. - Q: How is Thymosin Alpha-1 reconstituted and stored? A: Lyophilised Ta1 vials are stored at -20C and reconstituted with bacteriostatic water, swirled gently rather than shaken. The reconstituted solution is kept refrigerated at 2 to 8C, protected from light and used within 28 days. It is supplied for laboratory research only. **Referenced studies:** - Thymosin alpha 1: clinical uses and mechanisms, Expert Opin Biol Ther, 2007 (https://pubmed.ncbi.nlm.nih.gov/17716567/) - Thymosin alpha-1 activates TLR2 and TLR9 signalling, Nat Med, 2007 (https://pubmed.ncbi.nlm.nih.gov/17416776/) - Ta1 in severe sepsis: phase III trial, Intensive Care Med, 2013 (https://pubmed.ncbi.nlm.nih.gov/24161905/) ### Tirzepatide URL: https://milo-lab.com/products/tirzepatide/ Tirzepatide is a 39-amino-acid peptide with dual agonist activity at the GIP and GLP-1 receptors. Research compound, supplied as lyophilised powder. **Mechanism:** Tirzepatide is a single peptide with agonist activity at two incretin receptors, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Both are class B G-protein coupled receptors signalling through cAMP. The molecule carries a C20 fatty-diacid moiety that promotes reversible albumin binding, giving a plasma half-life of roughly five days. Its receptor selectivity is biased towards GIP relative to GLP-1. **FAQ:** - Q: What is tirzepatide? A: Tirzepatide (marketed as Mounjaro) is a once-weekly peptide that activates two metabolic receptors at the same time: GIP and GLP-1. This dual-agonist design makes it one of the most effective incretin compounds studied for type 2 diabetes and weight-loss research. - Q: How is tirzepatide reconstituted and stored? A: Bacteriostatic water is the standard solvent. Use 1 to 2ml per vial and swirl gently without shaking. Store lyophilised vials at -20C and the reconstituted solution at 2-8C, using it within 28 days. - Q: What receptors does tirzepatide bind? A: Two incretin receptors from one molecule: GIP and GLP-1. Both are class B G-protein coupled receptors signalling through cAMP, and the binding profile is biased towards GIP relative to GLP-1. - Q: Why is its half-life around five days? A: A C20 fatty-diacid moiety promotes reversible albumin binding, and aminoisobutyric acid substitutions at positions 2 and 13 resist cleavage by dipeptidyl peptidase-4. **Referenced studies:** - Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1), New England Journal of Medicine, 2022 (https://pubmed.ncbi.nlm.nih.gov/35658024/) - Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2), New England Journal of Medicine, 2021 (https://pubmed.ncbi.nlm.nih.gov/34170647/) ### Vitamin B12 1000 URL: https://milo-lab.com/products/vitamin-b12/ Methylcobalamin, the bioactive form of vitamin B12 (1000mcg/ml, 10ml vial), for energy metabolism, nerve and myelin health, and red blood cell formation. **Mechanism:** Vitamin B12 (cobalamin) is a water-soluble vitamin that mammals cannot synthesise. Milo-Lab supplies it as methylcobalamin, the coenzyme form, rather than as cyanocobalamin, which requires intracellular conversion. Methylcobalamin is the cofactor of methionine synthase, which converts homocysteine to methionine; adenosylcobalamin is the cofactor of methylmalonyl-CoA mutase. Parenteral presentations bypass the intrinsic-factor-dependent absorption pathway of the ileum. **FAQ:** - Q: What is the difference between methylcobalamin and cyanocobalamin? A: Cyanocobalamin is a synthetic form that the body has to convert into an active coenzyme, releasing a small cyanide molecule in the process. Methylcobalamin is already one of the two active coenzyme forms the body uses, so it is available immediately for methionine synthase and methylation reactions. Milo-Lab supplies methylcobalamin for this reason. - Q: What is vitamin B12 needed for in the body? A: B12 is a cofactor for methionine synthase (methylation, homocysteine recycling and DNA synthesis) and methylmalonyl-CoA mutase (mitochondrial energy metabolism). It is essential for red blood cell maturation and for maintaining the myelin sheath around nerves. Low B12 typically presents as fatigue, megaloblastic anaemia, elevated homocysteine and peripheral nerve symptoms. - Q: Which enzymes require B12 as a cofactor? A: Methylcobalamin is the cofactor of methionine synthase, which converts homocysteine to methionine. Adenosylcobalamin is the cofactor of methylmalonyl-CoA mutase. - Q: How is it supplied? A: As a 10 ml vial at 1000 mcg per ml, ready to use with no reconstitution required. Protect from light and return to refrigeration between uses. **Referenced studies:** - Vitamin B12 - Fact Sheet for Health Professionals, NIH Office of Dietary Supplements (https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/) - Methylcobalamin - Compound Summary, PubChem, NCBI (https://pubchem.ncbi.nlm.nih.gov/compound/Methylcobalamin) ### Wolverine Stack URL: https://milo-lab.com/products/wolverine-stack/ Wolverine Stack pairs BPC-157 and TB-500 (Thymosin Beta-4) in one recovery kit, combining local angiogenesis with systemic cell mobilisation for tissue repair. **Mechanism:** The Wolverine Stack combines two complementary repair peptides. BPC-157 promotes angiogenesis by upregulating VEGF and drives fibroblast proliferation at injury sites through FAK-paxillin signalling, building new blood supply and collagen scaffolding locally. TB-500, the synthetic fragment of Thymosin Beta-4, regulates actin sequestration in endothelial and other cells, enabling fast directed migration of repair cells through the whole body. Each peptide addresses a different phase of healing: BPC-157 handles local vascular and fibroblast activation, while TB-500 mobilises repair cells systemically. Used together, preclinical models report additive signalling in tissue-repair recovery effects that neither compound reaches alone. **FAQ:** - Q: How do BPC-157 and TB-500 work together? A: BPC-157 builds new blood vessels and collagen scaffolding directly at the injury site through VEGF and FAK-paxillin signalling. TB-500 regulates actin to mobilise repair cells across the whole body. Because one acts locally and the other systemically, the two peptides cover repair mechanisms that neither handles well on its own. - Q: How does the Wolverine Stack kit save money versus buying separately? A: The kit bundles one vial of BPC-157 and one vial of TB-500 at a single price that is lower than purchasing each peptide on its own. The exact saving depends on the variant selected. - Q: What are the half-lives of the two components? A: BPC-157 around four hours, TB-500 around eight to ten days. The difference in clearance is the reason the two are characterised separately. - Q: How is the kit supplied? A: Both peptides are supplied as separate lyophilised vials in one kit, each with its own certificate of analysis. ## Research Guides ### Bacteriostatic Water in Thailand: Where to Buy It & What to Check URL: https://milo-lab.com/blog/bacteriostatic-water-thailand/ Where researchers in Thailand buy bacteriostatic water, how it differs from sterile water, and the checks that matter before ordering multi-dose vials. ### BPC-157 in Thailand: Where to Buy, Price Ranges & What to Verify Before Ordering URL: https://milo-lab.com/blog/bpc-157-thailand-buying-guide/ BPC-157 for research in Thailand: what it costs, what a certificate of analysis should show, and the checks researchers should run before ordering from any supplier. ### GHK-Cu for Skin & Wound Repair: What the Research Says URL: https://milo-lab.com/blog/ghk-cu-skin-wound-repair-research/ GHK-Cu is a naturally occurring copper-binding tripeptide studied for its role in collagen synthesis, wound healing, and dermal gene expression. Here is what the mechanistic literature shows. ### Growth Hormone Secretagogues Explained: Ipamorelin, CJC-1295, Sermorelin & Tesamorelin Compared URL: https://milo-lab.com/blog/growth-hormone-secretagogues-compared/ A side-by-side look at the four most-studied growth hormone secretagogues, how each one signals the pituitary, and where they overlap or differ mechanistically. ### Is Milo Lab Legit? Testing, COAs & How to Verify Any Peptide Supplier URL: https://milo-lab.com/blog/is-milo-lab-legit/ A direct answer to a fair question: what you can verify about Milo-Lab right now, how batch testing works, and the red flags that disqualify any peptide supplier. ### KLOW vs Glow 70: Comparing Two Repair & Skin Peptide Blends URL: https://milo-lab.com/blog/klow-vs-glow-70-aesthetic-blends/ KLOW and Glow 70 are both multi-peptide repair-and-skin research blends built on the same core. The difference comes down to one component. Here is how they compare. ### Peptide Certificates of Analysis (COA): How to Read Them and Why They Matter URL: https://milo-lab.com/blog/reading-peptide-coa-guide/ A Certificate of Analysis (COA) is a third-party lab report confirming a peptide's identity, purity and quantity. Here is how to read one and what each section actually tells you. ### PT-141 (Bremelanotide): Mechanism, Reconstitution & Research Use URL: https://milo-lab.com/blog/pt-141-bremelanotide-guide/ PT-141 (bremelanotide) explained: how it activates MC4R in the hypothalamus, how it differs from PDE5 inhibitors, and how it is reconstituted for research. ### Reconstituting Peptides: A Bacteriostatic Water Guide (Ratios, Storage, Shelf Life) URL: https://milo-lab.com/blog/bacteriostatic-water-reconstitution-guide/ How to reconstitute lyophilised research peptides with bacteriostatic water: general ratios, swirl-not-shake technique, storage temperature and shelf life. ### Research Peptides and Clinical Services: How the Two Differ URL: https://milo-lab.com/blog/peptide-clinics-bangkok/ What clinical peptide services provide, how their pricing is structured, and how that differs from laboratory research material supplied without medical supervision. ### Retatrutide vs Semaglutide vs Tirzepatide: Comparing GLP-1 Research Peptides URL: https://milo-lab.com/blog/glp1-peptides-compared-retatrutide-semaglutide-tirzepatide/ Semaglutide, tirzepatide and retatrutide activate one, two and three metabolic receptors respectively. Here is how their mechanisms differ and what each is studied for. ### Retatrutide: Receptor Pharmacology and Regulatory Status URL: https://milo-lab.com/blog/retatrutide-thailand-guide/ Retatrutide (LY3437943): triple-receptor pharmacology, what the legal status of an investigational compound means in practice, and how the published trials were structured. ### Tesamorelin: Mechanism, Research Applications & Availability in Thailand URL: https://milo-lab.com/blog/tesamorelin-thailand-research/ Tesamorelin (Egrifta) explained: how the GHRH(1-44) analogue drives visceral fat research, its Phase 3 trial data, and how researchers source it in Thailand. ### What Research Peptide Material Costs, and Why Quotes Vary URL: https://milo-lab.com/blog/peptide-therapy-cost-thailand/ How the cost of peptide material breaks down, why quotes vary so widely, and what purity verification actually adds to the price. ### Where to Buy Research Peptides in Thailand: Bangkok, Phuket & Koh Samui URL: https://milo-lab.com/blog/buy-research-peptides-thailand/ A practical guide to ordering from Milo-Lab: product selection, payment, addresses and delivery within Thailand.